Cluster composition

Functions

Category	Name	IntersectionWithQuery	PValue	GenesInTerm	GenesInQuery	GenesInTermInQuery	ID
GeneOntologyMolecularFunction	extracellular matrix constituent, lubricant activity	MUC17 MUC3A	1.36e-04	4	96	2	GO:0030197
GeneOntologyBiologicalProcess	positive regulation of transcription by RNA polymerase II	TCEA1 TET2 HIVEP2 VGLL2 BCLAF1 CHD8 NR1D1 ABLIM1 KLF13 EGR1 ZNF827 NFATC3 PAX8 GLI2 FGFR1 TNFRSF1A OLIG1 POU2F3 CDON	2.54e-05	1390	98	19	GO:0045944
GeneOntologyBiologicalProcess	regulation of hepatic stellate cell activation	DDR2 NR1D1 FGFR1	3.64e-05	14	98	3	GO:2000489
GeneOntologyBiologicalProcess	hepatic stellate cell activation	DDR2 NR1D1 FGFR1	8.06e-05	18	98	3	GO:0035733
GeneOntologyBiologicalProcess	negative regulation of DNA-templated transcription	CUX2 CIART NACC1 BCLAF1 CHD8 XPO1 NR1D1 TRIM24 USP2 ZNF469 EGR1 ZNF827 NFATC3 GLI2 YLPM1 FGFR1 MAGEB17 PARP15	9.37e-05	1399	98	18	GO:0045892
GeneOntologyBiologicalProcess	skeletal muscle tissue development	VGLL2 USP2 EGR1 NFATC3 EMD PLEC CDON	9.45e-05	223	98	7	GO:0007519
GeneOntologyBiologicalProcess	negative regulation of RNA biosynthetic process	CUX2 CIART NACC1 BCLAF1 CHD8 XPO1 NR1D1 TRIM24 USP2 ZNF469 EGR1 ZNF827 NFATC3 GLI2 YLPM1 FGFR1 MAGEB17 PARP15	1.06e-04	1413	98	18	GO:1902679
GeneOntologyBiologicalProcess	circadian temperature homeostasis	NR1D1 EGR1	1.33e-04	4	98	2	GO:0060086
GeneOntologyBiologicalProcess	skeletal muscle organ development	VGLL2 USP2 EGR1 NFATC3 EMD PLEC CDON	1.49e-04	240	98	7	GO:0060538
GeneOntologyBiologicalProcess	locomotor rhythm	CIART USP2 EGR1	1.50e-04	22	98	3	GO:0045475
GeneOntologyBiologicalProcess	fibroblast activation	DDR2 NR1D1 FGFR1	1.96e-04	24	98	3	GO:0072537
GeneOntologyCellularComponent	nuclear body	SETD1B CIART BCLAF1 XPO1 CMYA5 SRCAP NR1D1 ALKBH5 WAC GLI2 YLPM1 SRRM2 POU2F3 AGAP3	7.08e-05	903	97	14	GO:0016604
GeneOntologyCellularComponent	Golgi lumen	MUC16 MUC12 MUC17 MUC3A MUC6	1.55e-04	109	97	5	GO:0005796
HumanPheno	Short neck	DDR2 SRCAP WAC TTC8 MEGF8 TRPM3 COG1 GLI2 FGFR1 EMD CTNND2 SRRM2	6.99e-06	398	35	12	HP:0000470
HumanPheno	Abnormal pelvic girdle bone morphology	HIVEP2 COL27A1 DDR2 SIK3 SRCAP BCR ZNF469 PHLDB1 MEGF8 TRPM3 COG1 GLI2 FGFR1 PLEC TNFRSF1A CDON	7.59e-06	730	35	16	HP:0002644
HumanPheno	Abnormal hip bone morphology	HIVEP2 COL27A1 DDR2 SIK3 SRCAP BCR ZNF469 PHLDB1 MEGF8 TRPM3 COG1 GLI2 FGFR1 TNFRSF1A CDON	9.64e-06	653	35	15	HP:0003272
HumanPheno	Immunologic hypersensitivity	TET2 SLC26A9 SIK3 SRCAP WAC TTC8 GLI2 FGFR1 CDON	1.74e-05	231	35	9	HP:0100326
HumanPheno	Abnormality of the cervical spine	DDR2 SRCAP WAC TTC8 MEGF8 TRPM3 COG1 GLI2 FGFR1 EMD CTNND2 SRRM2	1.92e-05	439	35	12	HP:0003319
HumanPheno	Abnormality of the falx cerebri	DDR2 GLI2 FGFR1 CDON	2.93e-05	27	35	4	HP:0010653
HumanPheno	Abnormality of globe location	HIVEP2 COL27A1 DDR2 CHD8 SIK3 SRCAP BCR WAC TTC8 MEGF8 TRPM3 KLF13 COG1 GLI2 FGFR1 PLEC CTNND2 SRRM2 CDON	2.97e-05	1122	35	19	HP:0100886
HumanPheno	Abnormal dura mater morphology	DDR2 GLI2 FGFR1 CDON	3.40e-05	28	35	4	HP:0010652
HumanPheno	Abnormal morphology of the nasal alae	HIVEP2 NACC1 COL27A1 DDR2 SRCAP BCR WAC MEGF8 TRPM3 COG1 GLI2 FGFR1 PLEC CDON	3.82e-05	639	35	14	HP:0000429
HumanPheno	Posteriorly rotated ears	MAP1B DDR2 CHD8 SRCAP WAC TTC8 MEGF8 COG1 GLI2 FGFR1 CTNND2 SRRM2	3.82e-05	470	35	12	HP:0000358
HumanPheno	Constipation	HIVEP2 PODXL CHD8 SIK3 SRCAP WAC PAX8 GLI2 SCN10A FGFR1 TNFRSF1A CDON	3.99e-05	472	35	12	HP:0002019
HumanPheno	Maladaptive fear-related cognitions	HIVEP2 SETD1B PODXL SLC26A9 CHD8 SRCAP WAC TTC8 GLI2 FGFR1 SRRM2 CDON	5.02e-05	483	35	12	HP:5200230
HumanPheno	Anxiety	HIVEP2 SETD1B PODXL SLC26A9 CHD8 SRCAP WAC TTC8 GLI2 FGFR1 SRRM2 CDON	5.02e-05	483	35	12	HP:0000739
HumanPheno	Abnormal nostril morphology	HIVEP2 NACC1 COL27A1 DDR2 SRCAP WAC MEGF8 TRPM3 COG1 GLI2 FGFR1 PLEC CDON	5.89e-05	575	35	13	HP:0005288
HumanPheno	Abnormal judgment	HIVEP2 SETD1B PODXL SLC26A9 CHD8 SRCAP WAC TTC8 GLI2 FGFR1 SRRM2 CDON	9.65e-05	516	35	12	HP:5200401
HumanPheno	Asthma	SLC26A9 SIK3 WAC TTC8 GLI2 FGFR1 CDON	9.91e-05	164	35	7	HP:0002099
HumanPheno	Absent P wave	SCN5A EMD	1.37e-04	3	35	2	HP:0033122
HumanPheno	Abnormality of globe location or size	HIVEP2 COL27A1 DDR2 CHD8 SIK3 SRCAP BCR WAC TTC8 MEGF8 TRPM3 KLF13 COG1 GLI2 FGFR1 PLEC CTNND2 SRRM2 CDON	1.38e-04	1246	35	19	HP:0000489
HumanPheno	Abnormal fear-induced behavior	HIVEP2 SETD1B PODXL SLC26A9 CHD8 SRCAP WAC TTC8 GLI2 FGFR1 SRRM2 CDON	1.45e-04	538	35	12	HP:0100852
HumanPheno	Abnormality of lower limb joint	HIVEP2 MAP1B COL27A1 DDR2 SIK3 SRCAP BCR ZNF469 PHLDB1 MEGF8 TRPM3 COG1 GLI2 FGFR1 EMD TNFRSF1A CDON	1.48e-04	1027	35	17	HP:0100491
HumanPheno	Midnasal atresia or stenosis	GLI2 FGFR1 CDON	1.57e-04	16	35	3	HP:0010642
HumanPheno	Abnormality of the midnasal cavity	GLI2 FGFR1 CDON	1.57e-04	16	35	3	HP:0010641
HumanPheno	Midnasal stenosis	GLI2 FGFR1 CDON	1.57e-04	16	35	3	HP:0010644
HumanPheno	Abnormality of the philtrum	HIVEP2 MAP1B DDR2 CHD8 SRCAP BCR TTC8 MEGF8 TRPM3 COG1 GLI2 FGFR1 SRRM2 CDON	1.59e-04	726	35	14	HP:0000288
HumanPheno	Abnormality of upper lip vermillion	HIVEP2 MAP1B CHD8 SRCAP BCR WAC COG1 GLI2 FGFR1 SRRM2 CDON	1.76e-04	464	35	11	HP:0011339
HumanPheno	Abnormal nasal cavity morphology	GLI2 FGFR1 CDON	1.89e-04	17	35	3	HP:0010640
HumanPheno	Abnormal experience of reality	CUX2 HIVEP2 SETD1B PODXL SLC26A9 CHD8 SRCAP WAC TTC8 GLI2 FGFR1 SRRM2 CDON	1.98e-04	646	35	13	HP:5200423
HumanPheno	Anteverted nares	HIVEP2 NACC1 COL27A1 SRCAP WAC MEGF8 TRPM3 COG1 GLI2 FGFR1 PLEC CDON	2.09e-04	559	35	12	HP:0000463
HumanPheno	Upturned nose	HIVEP2 NACC1 COL27A1 SRCAP WAC MEGF8 TRPM3 COG1 GLI2 FGFR1 PLEC CDON	2.09e-04	559	35	12	HP:0000427
HumanPheno	Abnormal periauricular region morphology	BCR WAC TRPM3 GLI2 FGFR1 CTNND2	2.27e-04	131	35	6	HP:0000383
HumanPheno	Sleep-wake cycle disturbance	CHD8 GLI2 FGFR1 CDON	2.28e-04	45	35	4	HP:0006979
HumanPheno	Abnormality of the neck	DDR2 SRCAP BCR WAC TTC8 PHLDB1 MEGF8 TRPM3 COG1 PAX8 GLI2 FGFR1 EMD CTNND2 SRRM2	2.54e-04	858	35	15	HP:0000464
HumanPheno	Abnormal neck morphology	DDR2 SRCAP BCR WAC TTC8 PHLDB1 MEGF8 TRPM3 COG1 GLI2 FGFR1 EMD CTNND2 SRRM2	2.85e-04	766	35	14	HP:0025668
HumanPheno	Abnormal hip joint morphology	HIVEP2 COL27A1 DDR2 SRCAP ZNF469 PHLDB1 TRPM3 COG1 GLI2 FGFR1 CDON	2.85e-04	490	35	11	HP:0001384
HumanPheno	Septo-optic dysplasia	GLI2 FGFR1 CDON	3.13e-04	20	35	3	HP:0100842
HumanPheno	Aplasia of the falx cerebri	GLI2 FGFR1 CDON	3.13e-04	20	35	3	HP:0010654
HumanPheno	Apathy	CUX2 PODXL GLI2 FGFR1 CDON	3.46e-04	91	35	5	HP:0000741
HumanPheno	Abnormal synovial membrane morphology	HIVEP2 COL27A1 DDR2 SRCAP ZNF469 PHLDB1 TRPM3 COG1 GLI2 FGFR1 CDON	3.59e-04	503	35	11	HP:0005262
HumanPheno	Proboscis	GLI2 FGFR1 CDON	3.63e-04	21	35	3	HP:0012806
HumanPheno	Cyclopia	GLI2 FGFR1 CDON	4.19e-04	22	35	3	HP:0009914
HumanPheno	Single naris	GLI2 FGFR1 CDON	4.19e-04	22	35	3	HP:0009932
HumanPheno	Narrow nasal bridge	SRCAP GLI2 FGFR1 CDON	4.31e-04	53	35	4	HP:0000446
HumanPheno	Short attention span	MAP1B PODXL CHD8 SRCAP BCR WAC TTC8 GLI2 FGFR1 SRRM2 CDON	4.56e-04	517	35	11	HP:0000736
HumanPheno	Abnormal joint physiology	MAP1B NACC1 COL27A1 DDR2 SIK3 SRCAP BCR TTC8 ZNF469 MEGF8 COG1 GLI2 SCN5A FGFR1 EMD PLEC TNFRSF1A CTNND2 CDON	4.65e-04	1358	35	19	HP:0034430
HumanPheno	Abnormality of joint mobility	MAP1B NACC1 COL27A1 DDR2 SIK3 SRCAP BCR TTC8 ZNF469 MEGF8 COG1 GLI2 SCN5A FGFR1 EMD PLEC TNFRSF1A CTNND2 CDON	4.65e-04	1358	35	19	HP:0011729
HumanPheno	Reduced attention regulation	MAP1B PODXL CHD8 SRCAP BCR WAC TTC8 GLI2 FGFR1 SRRM2 CDON	5.30e-04	526	35	11	HP:5200044
HumanPheno	Abnormal external nose morphology	HIVEP2 NACC1 COL27A1 DDR2 SRCAP BCR WAC MEGF8 TRPM3 COG1 GLI2 FGFR1 PLEC SRRM2 CDON	5.31e-04	916	35	15	HP:0010938
HumanPheno	Aplasia/Hypoplasia of the nares	GLI2 FGFR1 CDON	5.45e-04	24	35	3	HP:0100597
HumanPheno	Abnormal finger morphology	TET2 HIVEP2 SETD1B MAP1B COL27A1 DDR2 SIK3 SRCAP BCR WAC TTC8 ZNF469 MEGF8 TRPM3 KLF13 COG1 GLI2 FGFR1 PLEC	6.10e-04	1385	35	19	HP:0001167
HumanPheno	Abnormal heart rate variability	GLI2 FGFR1 CDON	6.16e-04	25	35	3	HP:0031860
HumanPheno	Midface retrusion	COL27A1 DDR2 WAC MEGF8 TRPM3 COG1 GLI2 FGFR1	6.25e-04	291	35	8	HP:0011800
HumanPheno	Abnormal P wave	SCN5A EMD	6.76e-04	6	35	2	HP:0031595
HumanPheno	Medial flaring of the eyebrow	HIVEP2 MAP1B WAC TTC8 KLF13 FGFR1 CDON	7.54e-04	228	35	7	HP:0010747
HumanPheno	Abnormal eyelid morphology	HIVEP2 SETD1B MAP1B DDR2 CHD8 SRCAP BCR WAC TTC8 ZNF469 MEGF8 TRPM3 KLF13 COG1 GLI2 FGFR1 PLEC CTNND2 SRRM2	7.63e-04	1408	35	19	HP:0000492
HumanPheno	Single central incisor	GLI2 FGFR1 CDON	7.76e-04	27	35	3	HP:0001573
HumanPheno	Solitary median maxillary central incisor	GLI2 FGFR1 CDON	7.76e-04	27	35	3	HP:0006315
HumanPheno	Abnormal stomach morphology	TET2 HIVEP2 MAP1B NACC1 PODXL SLC26A9 SRCAP BCR WAC GLI2 FGFR1 PLEC CDON	7.91e-04	742	35	13	HP:0002577
HumanPheno	Oromotor apraxia	GLI2 FGFR1 CDON	8.66e-04	28	35	3	HP:0007301
HumanPheno	Hyperactivity	CUX2 HIVEP2 MAP1B CHD8 SRCAP BCR WAC GLI2 FGFR1 SRRM2 CDON	8.78e-04	558	35	11	HP:0000752
HumanPheno	Decreased cervical spine flexion due to contractures of posterior cervical muscles	EMD PLEC	9.43e-04	7	35	2	HP:0004631
HumanPheno	Abnormal upper lip morphology	HIVEP2 MAP1B DDR2 CHD8 SRCAP BCR WAC TTC8 MEGF8 TRPM3 COG1 GLI2 FGFR1 SRRM2 CDON	1.11e-03	980	35	15	HP:0000177
HumanPheno	Abnormal thorax morphology	TET2 HIVEP2 MAP1B DDR2 SIK3 SRCAP BCR MEGF8 TRPM3 COG1 PAX8 GLI2 SCN5A FGFR1 EMD TNFRSF1A CTNND2 CDON	1.14e-03	1328	35	18	HP:0000765
HumanPheno	Short palm	DDR2 BCR WAC MEGF8 FGFR1	1.14e-03	118	35	5	HP:0004279
HumanPheno	Panhypopituitarism	GLI2 FGFR1 CDON	1.17e-03	31	35	3	HP:0000871
HumanPheno	Abnormality of the palpebral fissures	HIVEP2 SETD1B DDR2 CHD8 SRCAP BCR WAC TTC8 MEGF8 TRPM3 KLF13 COG1 FGFR1 CTNND2	1.22e-03	880	35	14	HP:0008050
HumanPheno	Abnormal basophil morphology	TET2 BCR	1.25e-03	8	35	2	HP:0001912
HumanPheno	Cloverleaf skull	MEGF8 FGFR1	1.25e-03	8	35	2	HP:0002676
HumanPheno	Abnormal curvature of the vertebral column	MAP1B NACC1 PODXL COL27A1 DDR2 SRCAP BCR ZNF469 MEGF8 TRPM3 COG1 GLI2 FGFR1 EMD PLEC CTNND2 CDON	1.26e-03	1219	35	17	HP:0010674
MousePheno	absent round window	PAX8 FGFR1	3.40e-05	2	82	2	MP:0030412
MousePheno	Leydig cell atrophy	DDR2 EGR1	3.40e-05	2	82	2	MP:0013599
Domain	SEA	MUC16 MUC12 MUC17 MUC3A	5.61e-06	23	97	4	PS50024
Domain	SEA_dom	MUC16 MUC12 MUC17 MUC3A	5.61e-06	23	97	4	IPR000082
Domain	SEA	MUC16 MUC17 MUC3A	4.74e-05	14	97	3	SM00200
Domain	MAP1	MAP1A MAP1B	7.98e-05	3	97	2	IPR026074
Domain	SEA	MUC16 MUC12 MUC17	1.95e-04	22	97	3	PF01390
Pathway	REACTOME_DEFECTIVE_GALNT3_CAUSES_HFTC	MUC16 MUC12 MUC17 MUC3A MUC6	1.26e-08	16	72	5	M27410
Pathway	REACTOME_DEFECTIVE_C1GALT1C1_CAUSES_TNPS	MUC16 MUC12 MUC17 MUC3A MUC6	1.78e-08	17	72	5	M27412
Pathway	REACTOME_TERMINATION_OF_O_GLYCAN_BIOSYNTHESIS	MUC16 MUC12 MUC17 MUC3A MUC6	9.46e-08	23	72	5	M556
Pathway	REACTOME_DECTIN_2_FAMILY	MUC16 MUC12 MUC17 MUC3A MUC6	1.83e-07	26	72	5	M27483
Pathway	REACTOME_O_LINKED_GLYCOSYLATION_OF_MUCINS	MUC16 MUC12 MUC17 MUC3A MUC6	1.56e-05	62	72	5	M546
Pathway	REACTOME_FGFR1_MUTANT_RECEPTOR_ACTIVATION	BAG4 TRIM24 BCR FGFR1	1.77e-05	31	72	4	M661
Pathway	REACTOME_DISEASES_ASSOCIATED_WITH_O_GLYCOSYLATION_OF_PROTEINS	MUC16 MUC12 MUC17 MUC3A MUC6	2.45e-05	68	72	5	M27303
Pathway	REACTOME_SIGNALING_BY_FGFR1_IN_DISEASE	BAG4 TRIM24 BCR FGFR1	4.05e-05	38	72	4	M27536
Pathway	REACTOME_C_TYPE_LECTIN_RECEPTORS_CLRS	MUC16 MUC12 NFATC3 MUC17 MUC3A MUC6	7.86e-05	140	72	6	M27484
Pathway	REACTOME_TERMINATION_OF_O_GLYCAN_BIOSYNTHESIS	MUC16 MUC17 MUC6	1.59e-04	21	72	3	MM15706
Pathway	REACTOME_O_LINKED_GLYCOSYLATION	MUC16 MUC12 MUC17 MUC3A MUC6	2.54e-04	111	72	5	M27416
Pathway	REACTOME_SIGNALING_BY_FGFR_IN_DISEASE	BAG4 TRIM24 BCR FGFR1	2.97e-04	63	72	4	M635
Pubmed	Spatiotemporal profile of postsynaptic interactomes integrates components of complex brain disorders.	SHROOM3 FXR2 NACC1 BCLAF1 ZBTB22 ARHGEF12 CHD8 SORBS1 SIK3 TTC3 BCR ABLIM1 NFATC3 TJP1 PRRC2C SIPA1L1 YLPM1 CTNND2 CABIN1 NUP153	2.58e-12	963	98	20	28671696
Pubmed	A central chaperone-like role for 14-3-3 proteins in human cells.	TET2 SHROOM3 HIVEP2 MAP1B SORBS1 SIK3 BCR ZCCHC14 ABLIM1 PHLDB1 MEGF8 NFATC3 TJP1 PRRC2C SIPA1L1 LPP PLEC SRRM2 AGAP3	3.43e-12	861	98	19	36931259
Pubmed	Mucin gene expression in human laryngeal epithelia: effect of laryngopharyngeal reflux.	MUC16 MUC12 MUC17 MUC3A MUC6	1.33e-09	18	98	5	18834073
Pubmed	A dual-activity topoisomerase complex regulates mRNA translation and turnover.	SHROOM3 HIVEP2 SETD1B CHD8 SRCAP TTC3 BCR TBC1D9 ZCCHC14 PHLDB1 SCAP MEGF8 ZNF827 SCN5A FGFR1 PLEC CABIN1 AGAP3	1.78e-09	1105	98	18	35748872
Pubmed	Chr21 protein-protein interactions: enrichment in proteins involved in intellectual disability, autism, and late-onset Alzheimer's disease.	TET2 ZSWIM8 HIVEP2 SORBS1 CMYA5 TTC3 NR1D1 FRMD4B WAC USP2 ABLIM1 COG1 TJP1 SIPA1L1 YLPM1 PLEC CTNND2 CABIN1 AGAP3	2.89e-09	1285	98	19	35914814
Pubmed	Construction of expression-ready cDNA clones for KIAA genes: manual curation of 330 KIAA cDNA clones.	SMG1 CUX2 CHD8 SIK3 ZCCHC14 ABLIM1 PHLDB1 SCAP SIPA1L1	1.62e-08	225	98	9	12168954
Pubmed	Comprehensive identification of phosphorylation sites in postsynaptic density preparations.	MAP1A MAP1B BCLAF1 SORBS1 PLEKHA6 ABLIM1 SIPA1L1 CTNND2 SRRM2	2.03e-08	231	98	9	16452087
Pubmed	Systematic bromodomain protein screens identify homologous recombination and R-loop suppression pathways involved in genome integrity.	ZSWIM8 MAP1A FXR2 NACC1 BAG4 CHD8 SIK3 SRCAP TRIM24 BCR ZNF469 ZNF827 SIPA1L1 SCN5A SRRM2 AGAP3	9.12e-08	1116	98	16	31753913
Pubmed	A human MAP kinase interactome.	HIVEP2 MAP1A CHD8 SORBS1 MUC12 PLEKHA6 SIK3 ABLIM1 EGR1 PLEC NUP153	1.33e-07	486	98	11	20936779
Pubmed	Molecular Characterization of the Oncogene BTF3 and Its Targets in Colorectal Cancer.	SMG1 SHROOM3 MAP1B FXR2 BCLAF1 C4orf54 ABLIM1 TJP1 SIPA1L1 EMD PLEC SRRM2	2.07e-07	626	98	12	33644029
Pubmed	Prediction of the coding sequences of mouse homologues of KIAA gene: II. The complete nucleotide sequences of 400 mouse KIAA-homologous cDNAs identified by screening of terminal sequences of cDNA clones randomly sampled from size-fractionated libraries.	SETD1B ARHGEF12 SORBS1 ZCCHC14 ABLIM1 PHLDB1 MEGF8 PRRC2C SIPA1L1 SRRM2	2.42e-07	407	98	10	12693553
Pubmed	N-Terminal Acetyltransferase Naa40p Whereabouts Put into N-Terminal Proteoform Perspective.	MAP1A MAP1B NACC1 BCLAF1 SRCAP WAC ABLIM1 TJP1 PRRC2C LPP YLPM1 EMD SMCR8 NUP153	3.71e-07	934	98	14	33916271
Pubmed	Proteome-scale mapping of binding sites in the unstructured regions of the human proteome.	SHROOM3 CUX2 MAP1A ZNF469 EGR1 GLI2 YLPM1 SCN10A PLEC NUP153	4.00e-07	430	98	10	35044719
Pubmed	Resolution of cell fate decisions revealed by single-cell gene expression analysis from zygote to blastocyst.	TCEA1 CUX2 ZBTB22 SRCAP NR1D1 TRIM24 ZCCHC14 ABLIM1 KLF13 EGR1 LPP OLIG1 POU2F3	4.56e-07	808	98	13	20412781
Pubmed	PRISMA and BioID disclose a motifs-based interactome of the intrinsically disordered transcription factor C/EBPα.	TCEA1 TET2 NACC1 BCLAF1 CHD8 XPO1 TRIM24 ALKBH5 WAC EGR1 PRRC2C ZBTB3 SRRM2 CDCA5 NUP153	4.69e-07	1103	98	15	34189442
Pubmed	Shotgun sequencing of the human transcriptome with ORF expressed sequence tags.	SMG1 ZSWIM8 PODXL MUC16 PLEKHA6 ZCCHC2 TBC1D9 TJP1 TMEM209 FGD5 MUC3A	4.70e-07	552	98	11	10737800
Pubmed	Qualitative and quantitative analyses of protein phosphorylation in naive and stimulated mouse synaptosomal preparations.	MAP1A MAP1B SORBS1 PLEKHA6 ABLIM1 SIPA1L1 PLEC CTNND2 SRRM2	6.37e-07	347	98	9	17114649
Pubmed	Large-scale characterization of HeLa cell nuclear phosphoproteins.	TCEA1 NACC1 BCLAF1 XPO1 NR1D1 TBC1D9 ABLIM1 SIPA1L1 YLPM1 PLEC SRRM2 NUP153	1.92e-06	774	98	12	15302935
Pubmed	TNF-α inhibits glucocorticoid receptor-induced gene expression by reshaping the GR nuclear cofactor profile.	SMG1 FXR2 NACC1 MUC16 SIK3 TRIM24 PHLDB1 MEGF8 FGD5 CTNND2 SMCR8	1.92e-06	638	98	11	31182584
Pubmed	Robust phosphoproteomic profiling of tyrosine phosphorylation sites from human T cells using immobilized metal affinity chromatography and tandem mass spectrometry.	FXR2 BCR ABLIM1 LPP EMD SRRM2	2.20e-06	133	98	6	15144186
Pubmed	Functional proteomics establishes the interaction of SIRT7 with chromatin remodeling complexes and expands its role in regulation of RNA polymerase I transcription.	ZSWIM8 MAP1B FXR2 CHD8 XPO1 TJP1 PRRC2C YLPM1 PLEC SRRM2 NUP153	2.40e-06	653	98	11	22586326
Pubmed	KCTD13-mediated ubiquitination and degradation of GluN1 regulates excitatory synaptic transmission and seizure susceptibility.	MAP1A MAP1B BCLAF1 ARHGEF12 SORBS1 PLEKHA6 XPO1 BCR ABLIM1 PHLDB1 TJP1 PRRC2C SIPA1L1 PLEC CTNND2 AGAP3	2.44e-06	1431	98	16	37142655
Pubmed	Destabilization of Atoh1 by E3 Ubiquitin Ligase Huwe1 and Casein Kinase 1 Is Essential for Normal Sensory Hair Cell Development.	MAP1A MAP1B PRRC2C PLEC SRRM2	2.53e-06	76	98	5	27542412
Pubmed	Prediction of the coding sequences of mouse homologues of KIAA gene: III. the complete nucleotide sequences of 500 mouse KIAA-homologous cDNAs identified by screening of terminal sequences of cDNA clones randomly sampled from size-fractionated libraries.	TET2 SMG1 SHROOM3 BCLAF1 CHD8 SIK3 BCR FRMD4B GRAMD4 TMEM131L	2.58e-06	529	98	10	14621295
Pubmed	The Nse5/6-like SIMC1-SLF2 complex localizes SMC5/6 to viral replication centers.	TCEA1 MAP1B BCLAF1 CHD8 TRIM24 WAC TJP1 PRRC2C YLPM1 EMD SRRM2 CDCA5 NUP153	2.87e-06	954	98	13	36373674
Pubmed	The TRIM9/TRIM67 neuronal interactome reveals novel activators of morphogenesis.	SORBS1 ZCCHC14 ABLIM1 PHLDB1 SIPA1L1 LPP CTNND2	2.95e-06	218	98	7	33378226
Pubmed	Neuron-specific protein network mapping of autism risk genes identifies shared biological mechanisms and disease-relevant pathologies.	MAP1A MAP1B FXR2 BCLAF1 SORBS1 BCR ABLIM1 TJP1 PRRC2C SIPA1L1 EMD PLEC CTNND2 AGAP3	3.80e-06	1139	98	14	36417873
Pubmed	Network organization of the human autophagy system.	WIPI1 MAP1A MAP1B FXR2 XPO1 TJP1 YLPM1 EMD SMCR8	4.22e-06	437	98	9	20562859
Pubmed	Reciprocal interaction between SIRT6 and APC/C regulates genomic stability.	SMG1 SETD1B FXR2 BCLAF1 CHD8 SRCAP YLPM1 TMEM209 NUP153	4.46e-06	440	98	9	34244565
Pubmed	Identification of proximal SUMO-dependent interactors using SUMO-ID.	MAP1A MAP1B CHD8 TRIM24 ABLIM1 COG1 TJP1 LPP EMD	4.79e-06	444	98	9	34795231
Pubmed	A Degradation Motif in STAU1 Defines a Novel Family of Proteins Involved in Inflammation.	TCEA1 MAP1A MAP1B FXR2 BCLAF1 TTC3 BCR TJP1 PRRC2C YLPM1 PLEC	6.40e-06	724	98	11	36232890
Pubmed	Genome-wide CRISPR screens identify novel regulators of wild-type and mutant p53 stability.	ZSWIM8 SETD1B MAP1A SORBS1 ZCCHC2 SRCAP BCR ALKBH5 NFATC3 PRRC2C	6.53e-06	588	98	10	38580884
Pubmed	A protein-RNA interaction atlas of the ribosome biogenesis factor AATF.	FXR2 BCLAF1 TJP1 PRRC2C YLPM1 SRRM2	6.88e-06	162	98	6	31363146
Pubmed	The STUbL RNF4 regulates protein group SUMOylation by targeting the SUMO conjugation machinery.	PODXL VGLL2 BCLAF1 DDR2 CHD8 XPO1 WAC ABLIM1 TJP1 GLI2 TMEM209 EMD PLEC SRRM2	7.09e-06	1203	98	14	29180619
Pubmed	An antibody-based proximity labeling map reveals mechanisms of SARS-CoV-2 inhibition of antiviral immunity.	FXR2 BCR FRMD4B ZCCHC14 ABLIM1 SCAP TJP1 LPP YLPM1 TMEM209 TMEM131L	7.19e-06	733	98	11	34672954
Pubmed	Whole genome sequencing resource identifies 18 new candidate genes for autism spectrum disorder.	BCLAF1 SRCAP WAC	7.72e-06	14	98	3	28263302
Pubmed	A common genetic variant within SCN10A modulates cardiac SCN5A expression.	SCN5A SCN10A	7.86e-06	2	98	2	24642470
Pubmed	Emerin binding to Btf, a death-promoting transcriptional repressor, is disrupted by a missense mutation that causes Emery-Dreifuss muscular dystrophy.	BCLAF1 EMD	7.86e-06	2	98	2	15009215
Pubmed	Regulation of microtubule-associated protein 1B (MAP1B) subunit composition.	MAP1A MAP1B	7.86e-06	2	98	2	11002287
Pubmed	Novel isoforms of the sodium channels Nav1.8 and Nav1.5 are produced by a conserved mechanism in mouse and rat.	SCN5A SCN10A	7.86e-06	2	98	2	15047701
Pubmed	Critical individual roles of the BCR and FGFR1 kinase domains in BCR-FGFR1-driven stem cell leukemia/lymphoma syndrome.	BCR FGFR1	7.86e-06	2	98	2	31525277
Pubmed	TNF-α enhances the currents of voltage gated sodium channels in uninjured dorsal root ganglion neurons following motor nerve injury.	SCN10A TNFRSF1A	7.86e-06	2	98	2	21145890
Pubmed	Heterotypic complex formation between subunits of microtubule-associated proteins 1A and 1B is due to interaction of conserved domains.	MAP1A MAP1B	7.86e-06	2	98	2	16996626
Pubmed	Altered signaling of TNFalpha-TNFR1 and SODD/BAG4 is responsible for radioresistance in human HT-R15 cells.	BAG4 TNFRSF1A	7.86e-06	2	98	2	12017295
Pubmed	The mouse and rat MAP1B genes: genomic organization and alternative transcription.	MAP1A MAP1B	7.86e-06	2	98	2	9615228
Pubmed	Mutations in SCN10A are responsible for a large fraction of cases of Brugada syndrome.	SCN5A SCN10A	7.86e-06	2	98	2	24998131
Pubmed	A case of 8p11 myeloproliferative syndrome with BCR-FGFR1 gene fusion presenting with trilineage acute leukemia/lymphoma, successfully treated by cord blood transplantation.	BCR FGFR1	7.86e-06	2	98	2	23171834
Pubmed	From GWAS to function: genetic variation in sodium channel gene enhancer influences electrical patterning.	SCN5A SCN10A	7.86e-06	2	98	2	24360055
Pubmed	Delayed development of nervous system in mice homozygous for disrupted microtubule-associated protein 1B (MAP1B) gene.	MAP1A MAP1B	7.86e-06	2	98	2	9199175
Pubmed	Single nucleotide polymorphisms of SCN5A and SCN10A genes increase the risk of ventricular arrhythmias during myocardial infarction.	SCN5A SCN10A	7.86e-06	2	98	2	32330377
Pubmed	Cloning of human microtubule-associated protein 1B and the identification of a related gene on chromosome 15.	MAP1A MAP1B	7.86e-06	2	98	2	7806212
Pubmed	Oligodendrocyte dysfunction due to Chd8 mutation gives rise to behavioral deficits in mice.	CHD8 OLIG1	7.86e-06	2	98	2	32142125
Pubmed	Chd8 mutation in oligodendrocytes alters microstructure and functional connectivity in the mouse brain.	CHD8 OLIG1	7.86e-06	2	98	2	33228730
Pubmed	Comparable clinical characteristics in Brugada syndrome patients harboring SCN5A or novel SCN10A variants.	SCN5A SCN10A	7.86e-06	2	98	2	31292628
Pubmed	Functional characterization of two rare BCR-FGFR1+ leukemias.	BCR FGFR1	7.86e-06	2	98	2	31980503
Pubmed	Fusion of the BCR and the fibroblast growth factor receptor-1 (FGFR1) genes as a result of t(8;22)(p11;q11) in a myeloproliferative disorder: the first fusion gene involving BCR but not ABL.	BCR FGFR1	7.86e-06	2	98	2	11746971
Pubmed	FGFR1 promotes the stem cell-like phenotype of FGFR1-amplified non-small cell lung cancer cells through the Hedgehog pathway.	GLI2 FGFR1	7.86e-06	2	98	2	26936993
Pubmed	Neuronal abnormalities in microtubule-associated protein 1B mutant mice.	MAP1A MAP1B	7.86e-06	2	98	2	8577753
Pubmed	Molecular cloning of microtubule-associated protein 1 (MAP1A) and microtubule-associated protein 5 (MAP1B): identification of distinct genes and their differential expression in developing brain.	MAP1A MAP1B	7.86e-06	2	98	2	2355215
Pubmed	Signal transduction of pregnenolone sulfate in insulinoma cells: activation of Egr-1 expression involving TRPM3, voltage-gated calcium channels, ERK, and ternary complex factors.	TRPM3 EGR1	7.86e-06	2	98	2	21257751
Pubmed	Impact of CUX2 on the female mouse liver transcriptome: activation of female-biased genes and repression of male-biased genes.	CUX2 TRIM24	7.86e-06	2	98	2	22966202
Pubmed	A genome-wide linkage scan for cleft lip and cleft palate identifies a novel locus on 8p11-23.	BAG4 FGFR1	7.86e-06	2	98	2	17366557
Pubmed	SR protein kinases promote splicing of nonconsensus introns.	FXR2 BCLAF1 ARHGEF12 PHLDB1 PRRC2C CTNND2 SRRM2 NUP153	8.71e-06	361	98	8	26167880
Pubmed	RNF43 inhibits WNT5A-driven signaling and suppresses melanoma invasion and resistance to the targeted therapy.	ABLIM1 TJP1 LPP TMEM209 TMEM131L EMD NUP153	1.01e-05	263	98	7	34702444
Pubmed	Human transcription factor protein interaction networks.	TET2 SMG1 NACC1 CHD8 SRCAP FIGN TRIM24 NFATC3 PAX8 PRRC2C GLI2 YLPM1 EMD CABIN1 SRRM2	1.11e-05	1429	98	15	35140242
Pubmed	Common variants in 22 loci are associated with QRS duration and cardiac ventricular conduction.	SIPA1L1 SCN5A SCN10A	1.43e-05	17	98	3	21076409
Pubmed	Kelch Domain of Gigaxonin Interacts with Intermediate Filament Proteins Affected in Giant Axonal Neuropathy.	BCLAF1 ARHGEF12 ZNF469 PHLDB1 SCN5A PLEC	1.56e-05	187	98	6	26460568
Pubmed	SMYD3 Impedes Small Cell Lung Cancer Sensitivity to Alkylation Damage through RNF113A Methylation-Phosphorylation Cross-talk.	TET2 FXR2 BCLAF1 SIK3 PRRC2C YLPM1 EMD PLEC SRRM2 NUP153	1.66e-05	655	98	10	35819319
Pubmed	Identification and selected reaction monitoring (SRM) quantification of endocytosis factors associated with Numb.	BCLAF1 BCR SRRM2	1.72e-05	18	98	3	23211419
Pubmed	Hsp90 cochaperone Aha1 downregulation rescues misfolding of CFTR in cystic fibrosis.	SHROOM3 PLEKHA6 XPO1 BCR TJP1 EMD	1.97e-05	195	98	6	17110338
Pubmed	Systematic Determination of Human Cyclin Dependent Kinase (CDK)-9 Interactome Identifies Novel Functions in RNA Splicing Mediated by the DEAD Box (DDX)-5/17 RNA Helicases.	ABLIM1 TJP1 PRRC2C SIPA1L1 EMD PLEC SRRM2	2.11e-05	295	98	7	26209609
Pubmed	Contributions of the RhoGEF activity of p210 BCR/ABL to disease progression.	ARHGEF12 BCR	2.35e-05	3	98	2	23207522
Pubmed	Differential Expression of MUC12, MUC16, and MUC20 in Patients with Active and Remission Ulcerative Colitis.	MUC16 MUC12	2.35e-05	3	98	2	26770020
Pubmed	Genomic organization and structure of the 3' region of human MUC3: alternative splicing predicts membrane-bound and soluble forms of the mucin.	MUC17 MUC3A	2.35e-05	3	98	2	10512748
Pubmed	Interaction of tubby-like protein-1 (Tulp1) and microtubule-associated protein (MAP) 1A and MAP1B in the mouse retina.	MAP1A MAP1B	2.35e-05	3	98	2	24664738
Pubmed	Interaction of PDZRhoGEF with microtubule-associated protein 1 light chains: link between microtubules, actin cytoskeleton, and neuronal polarity.	MAP1A MAP1B	2.35e-05	3	98	2	16478718
Pubmed	Overexpression of the 'silencer of death domain', SODD/BAG-4, modulates both TNFR1- and CD95-dependent cell death pathways.	BAG4 TNFRSF1A	2.35e-05	3	98	2	12706861
Pubmed	High prevalence of concealed Brugada syndrome in patients with atrioventricular nodal reentrant tachycardia.	SCN5A SCN10A	2.35e-05	3	98	2	25998140
Pubmed	TET2-BCLAF1 transcription repression complex epigenetically regulates the expression of colorectal cancer gene Ascl2 via methylation of its promoter.	TET2 BCLAF1	2.35e-05	3	98	2	35660018
Pubmed	MAP 1A and MAP 1B are structurally related microtubule associated proteins with distinct developmental patterns in the CNS.	MAP1A MAP1B	2.35e-05	3	98	2	2470876
Pubmed	Microtubule-associated proteins, MAP 1A and MAP 1B, interact with F-actin in vitro.	MAP1A MAP1B	2.35e-05	3	98	2	7908020
Pubmed	Hepatocyte SREBP signaling mediates clock communication within the liver.	NR1D1 SCAP	2.35e-05	3	98	2	37066875
Pubmed	The light chains of microtubule-associated proteins MAP1A and MAP1B interact with α1-syntrophin in the central and peripheral nervous system.	MAP1A MAP1B	2.35e-05	3	98	2	23152929
Pubmed	Impact of cytosine methylation on DNA binding specificities of human transcription factors.	CUX2 ZBTB22 NR1D1 KLF13 EGR1 NFATC3 PAX8 GLI2 POU2F3	2.40e-05	544	98	9	28473536
Pubmed	Pro-prion, as a membrane adaptor protein for E3 ligase c-Cbl, facilitates the ubiquitination of IGF-1R, promoting melanoma metastasis.	MAP1B PODXL ACAD10 XPO1 SIK3 TRIM24 ABLIM1 TRPM3 LPP FGD5	2.55e-05	689	98	10	36543142
Pubmed	SRCAP complex promotes lung cancer progression by reprograming the oncogenic transcription of Hippo-YAP/TAZ signaling pathway.	MAP1B BCLAF1 CHD8 SRCAP ABLIM1 TJP1 PRRC2C LPP YLPM1	2.58e-05	549	98	9	38280479
Pubmed	The human cytoplasmic dynein interactome reveals novel activators of motility.	LCA5 SHROOM3 FXR2 SORBS1 SIK3 BCR NFATC3 TJP1 SIPA1L1 TMEM209 PLEC	2.92e-05	853	98	11	28718761
Pubmed	Protein interactome reveals converging molecular pathways among autism disorders.	ZSWIM8 FXR2 ZCCHC2 NR1D1 TBC1D9 PHLDB1 MEGF8 SIPA1L1 AGAP3	3.01e-05	560	98	9	21653829
Pubmed	Identifying biological pathways that underlie primordial short stature using network analysis.	MAP1B BCLAF1 XPO1 SRCAP ABLIM1 PHLDB1 TJP1 YLPM1 EMD PLEC SRRM2 NUP153	3.16e-05	1024	98	12	24711643
Pubmed	E-cadherin interactome complexity and robustness resolved by quantitative proteomics.	SHROOM3 ARHGEF12 SORBS1 PLEKHA6 ABLIM1 TJP1 LPP EMD PLEC	3.23e-05	565	98	9	25468996
Pubmed	A genome-wide screen to identify transcription factors expressed in pelvic Ganglia of the lower urinary tract.	TCEA1 CUX2 HIVEP2 ZBTB22 NR1D1 ZCCHC14 ABLIM1 GLI2 ZBTB3 POU2F3	3.25e-05	709	98	10	22988430
Pubmed	Interaction of LATS1 with SMAC links the MST2/Hippo pathway with apoptosis in an IAP-dependent manner.	TET2 MAP1B FXR2 EMD PLEC SRRM2	4.08e-05	222	98	6	35941108
Pubmed	The P-body component USP52/PAN2 is a novel regulator of HIF1A mRNA stability.	TET2 MAP1B BCLAF1 TJP1 EMD PLEC SRRM2	4.13e-05	328	98	7	23398456
Pubmed	Distinct Tumor Necrosis Factor Alpha Receptors Dictate Stem Cell Fitness versus Lineage Output in Dnmt3a-Mutant Clonal Hematopoiesis.	FGD5 TNFRSF1A	4.70e-05	4	98	2	36169447
Pubmed	Tumor necrosis factor receptor 1 is an ATPase regulated by silencer of death domain.	BAG4 TNFRSF1A	4.70e-05	4	98	2	11909948
Pubmed	Genome-wide association studies of the PR interval in African Americans.	SCN5A SCN10A	4.70e-05	4	98	2	21347284
Pubmed	Distinct kinetic and mechanical properties govern mucin 16- and podocalyxin-mediated tumor cell adhesion to E- and L-selectin in shear flow.	PODXL MUC16	4.70e-05	4	98	2	26329844
Pubmed	Mechanistic insights of NAC1 nuclear export and its role in ovarian cancer resistance to docetaxel.	NACC1 XPO1	4.70e-05	4	98	2	37019189
Pubmed	Circadian lipid synthesis in brown fat maintains murine body temperature during chronic cold.	NR1D1 SCAP	4.70e-05	4	98	2	31451658
Pubmed	Fibroblast growth factor signaling in oligodendrocyte-lineage cells facilitates recovery of chronically demyelinated lesions but is redundant in acute lesions.	FGFR1 OLIG1	4.70e-05	4	98	2	25913734
Interaction	YWHAH interactions	TET2 LCA5 SHROOM3 HIVEP2 FXR2 SORBS1 XPO1 SIK3 BCR ZCCHC14 ABLIM1 PHLDB1 MEGF8 NFATC3 TJP1 PRRC2C SIPA1L1 LPP PLEC SRRM2 AGAP3	5.83e-08	1102	98	21	int:YWHAH
Interaction	SFN interactions	TET2 SHROOM3 MAP1A MAP1B SORBS1 SIK3 BCR ABLIM1 PHLDB1 NFATC3 TJP1 PRRC2C SIPA1L1 PLEC SRRM2	1.21e-06	692	98	15	int:SFN
Interaction	ZYX interactions	CASS4 SHROOM3 SORBS1 XPO1 ABLIM1 TJP1 SIPA1L1 LPP FGFR1 SMCR8	4.61e-06	329	98	10	int:ZYX
Interaction	CNOT3 interactions	MAP1A MAP1B FXR2 XPO1 TRIM24 PRRC2C GLI2 AGAP3	7.72e-06	207	98	8	int:CNOT3
Interaction	SYNE3 interactions	SHROOM3 SORBS1 ZCCHC2 ZCCHC14 ABLIM1 SIPA1L1 LPP TMEM209 TMEM131L EMD PLEC	1.05e-05	444	98	11	int:SYNE3
Interaction	VASP interactions	SHROOM3 MAP1A ARHGEF12 SORBS1 XPO1 BCR TJP1 SIPA1L1 LPP	1.34e-05	294	98	9	int:VASP
Interaction	VAV1 interactions	SORBS1 XPO1 BCR ABLIM1 GLI2 FGFR1 EMD PLEC	1.56e-05	228	98	8	int:VAV1
Interaction	TNIK interactions	FXR2 CHD8 XPO1 BCR ABLIM1 TJP1 SIPA1L1 FGFR1 CTNND2 CABIN1	1.66e-05	381	98	10	int:TNIK
Interaction	NAA16 interactions	TCEA1 FGFR1 CDCA5 ALPK2	1.93e-05	33	98	4	int:NAA16
Interaction	YWHAG interactions	TET2 LCA5 SHROOM3 HIVEP2 BCLAF1 SH2D3C SORBS1 XPO1 SIK3 BCR ABLIM1 PHLDB1 NFATC3 TJP1 PRRC2C SIPA1L1 SRRM2 AGAP3	2.87e-05	1248	98	18	int:YWHAG
Interaction	CACNA1A interactions	MAP1B MEGF8 SCN5A YLPM1 SCN10A OLIG1	3.04e-05	123	98	6	int:CACNA1A
Interaction	YWHAE interactions	TET2 LCA5 SHROOM3 HIVEP2 MAP1B SORBS1 XPO1 SIK3 TTC3 BCR FRMD4B ABLIM1 PHLDB1 SIPA1L1 FGD5 EMD SRRM2 AGAP3	3.13e-05	1256	98	18	int:YWHAE
Interaction	RNF43 interactions	FXR2 BAG4 TRIM24 ABLIM1 TJP1 LPP TMEM209 TMEM131L EMD NUP153	4.37e-05	427	98	10	int:RNF43
Interaction	ATOH1 interactions	MAP1A MAP1B PRRC2C PLEC SRRM2	4.42e-05	80	98	5	int:ATOH1
Interaction	CTNNA1 interactions	DDR2 SORBS1 PLEKHA6 BCR ABLIM1 TJP1 SIPA1L1 LPP FGFR1	4.91e-05	347	98	9	int:CTNNA1
Interaction	MYCBP2 interactions	BCLAF1 SORBS1 NR1D1 TBC1D9 ABLIM1 NFATC3 TJP1 PRRC2C ALPK2	5.85e-05	355	98	9	int:MYCBP2
Interaction	ACTB interactions	TCEA1 TET2 MAP1A MAP1B PODXL SORBS1 SRCAP ABLIM1 TJP1 SIPA1L1 LPP SCN10A FGD5 FGFR1 EMD PLEC	6.40e-05	1083	98	16	int:ACTB
Interaction	NR3C1 interactions	SMG1 FXR2 NACC1 MUC16 SIK3 TRIM24 USP2 PHLDB1 MEGF8 EGR1 FGD5 CTNND2 ZBTB3 SMCR8 NUP153	7.00e-05	974	98	15	int:NR3C1
Interaction	TOP3B interactions	SHROOM3 HIVEP2 SETD1B FXR2 CHD8 SRCAP TTC3 BCR TBC1D9 ZCCHC14 PHLDB1 SCAP MEGF8 ZNF827 SCN5A FGFR1 PLEC CABIN1 AGAP3	7.43e-05	1470	98	19	int:TOP3B
Interaction	YWHAQ interactions	TET2 LCA5 SHROOM3 HIVEP2 SORBS1 SIK3 BCR ABLIM1 PHLDB1 NFATC3 TJP1 SIPA1L1 FGD5 EMD PLEC CABIN1	9.30e-05	1118	98	16	int:YWHAQ
Interaction	CTNNB1 interactions	SHROOM3 DDR2 CHD8 SORBS1 PLEKHA6 XPO1 USP2 EGR1 TJP1 SIPA1L1 FGFR1 EMD CTNND2 SRRM2 CDON	1.04e-04	1009	98	15	int:CTNNB1
Interaction	YWHAB interactions	TET2 LCA5 SHROOM3 SORBS1 SIK3 BCR ABLIM1 PHLDB1 NFATC3 TJP1 SIPA1L1 FGFR1 EMD SRRM2 AGAP3	1.10e-04	1014	98	15	int:YWHAB
Interaction	FOXK2 interactions	SETD1B MAP1B DDR2 XPO1 PRRC2C TNFRSF1A ZBTB3	1.15e-04	225	98	7	int:FOXK2
Interaction	CDK9 interactions	TCEA1 SETD1B SRCAP TRIM24 ABLIM1 TJP1 PRRC2C SIPA1L1 FGFR1 EMD PLEC SRRM2	1.21e-04	685	98	12	int:CDK9
Interaction	SMG7 interactions	SMG1 ZSWIM8 FXR2 NACC1 CHD8 XPO1 TRIM24 YLPM1	1.65e-04	319	98	8	int:SMG7
Interaction	SCAI interactions	BCR TNFRSF1A CDCA5 NUP153	2.08e-04	60	98	4	int:SCAI
Cytoband	11q23.3	ARHGEF12 SIK3 USP2 PHLDB1 POU2F3	7.46e-07	78	98	5	11q23.3
Cytoband	12q24.12	CUX2 ACAD10	9.41e-05	7	98	2	12q24.12
Cytoband	Ensembl 112 genes in cytogenetic band chr11q23	ARHGEF12 SIK3 USP2 PHLDB1 POU2F3	1.14e-04	220	98	5	chr11q23
GeneFamily	CD molecules\|Mucins	MUC16 MUC12 MUC17 MUC3A MUC6	2.37e-08	21	77	5	648
GeneFamily	Sodium voltage-gated channel alpha subunits	SCN5A SCN10A	6.32e-04	9	77	2	1203
GeneFamily	WD repeat domain containing\|GRAM domain containing\|BEACH domain containing	GRAMD4 TBC1D9	1.35e-03	13	77	2	1146
GeneFamily	Pleckstrin homology domain containing\|Rho guanine nucleotide exchange factors\|C2 domain containing	PLEKHA6 BCR PHLDB1 FGD5 AGAP3	1.86e-03	206	77	5	682
GeneFamily	Pleckstrin homology domain containing\|Rho guanine nucleotide exchange factors\|C2 domain containing	ARHGEF12 BCR FGD5	2.80e-03	66	77	3	722
GeneFamily	PDZ domain containing	SHROOM3 ARHGEF12 TJP1 SIPA1L1	4.04e-03	152	77	4	1220
Coexpression	LAKE_ADULT_KIDNEY_C3_PROXIMAL_TUBULE_EPITHELIAL_CELLS_S1_S2	PLEKHA6 FRMD4B ABLIM1 TRPM3 PAX8 PRRC2C SIPA1L1 LPP SRRM2	1.50e-07	221	98	9	M39222
Coexpression	GOBERT_OLIGODENDROCYTE_DIFFERENTIATION_DN	TET2 WIPI1 MAP1A MAP1B COL27A1 SORBS1 SRCAP FRMD4B WAC ABLIM1 PHLDB1 KLF13 PRRC2C YLPM1 PLEC CABIN1	3.16e-06	1102	98	16	M2369
Coexpression	LAKE_ADULT_KIDNEY_C5_PROXIMAL_TUBULE_EPITHELIAL_CELLS_STRESS_INFLAM	FXR2 COL27A1 PLEKHA6 FRMD4B TRPM3 EGR1 PAX8 PRRC2C SRRM2 CDON	3.76e-06	417	98	10	M39224
Coexpression	GOBERT_OLIGODENDROCYTE_DIFFERENTIATION_DN	TET2 WIPI1 MAP1A MAP1B COL27A1 SORBS1 SRCAP FRMD4B WAC ABLIM1 PHLDB1 KLF13 PRRC2C YLPM1 PLEC CABIN1	4.07e-06	1124	98	16	MM1070
Coexpression	LAKE_ADULT_KIDNEY_C2_PODOCYTES	TET2 HIVEP2 PODXL ARHGEF12 SIK3 CMYA5 TJP1	1.52e-05	212	98	7	M39221
Coexpression	MANNO_MIDBRAIN_NEUROTYPES_HENDO	WIPI1 PODXL SH2D3C ARHGEF12 NR1D1 FRMD4B ABLIM1 KLF13 EGR1 TJP1 LPP FGD5 TNFRSF1A	2.67e-05	888	98	13	M39049
Coexpression	SENESE_HDAC1_AND_HDAC2_TARGETS_DN	WIPI1 FIGN ABLIM1 GLI2 TMEM131L FGFR1 ALPK2	3.20e-05	238	98	7	M12004
Coexpression	LAKE_ADULT_KIDNEY_C17_COLLECTING_SYSTEM_PCS_STRESSED_DISSOC_SUBSET	SHROOM3 HIVEP2 ARHGEF12 SIK3 ABLIM1 EGR1 TJP1	3.37e-05	240	98	7	M39236
Coexpression	LAKE_ADULT_KIDNEY_C4_PROXIMAL_TUBULE_EPITHELIAL_CELLS_S2	SHROOM3 ABLIM1 PAX8 SIPA1L1 LPP ALPK2	5.31e-05	176	98	6	M39223
Coexpression	FOURATI_BLOOD_TWINRIX_AGE_25_83YO_RESPONDERS_VS_POOR_RESPONDERS_0DY_UP	TCEA1 HIVEP2 PODXL BCLAF1 XPO1 TTC3 ADGRG4 TBC1D9 ABLIM1 POU2F3	7.04e-05	587	98	10	M40869
Coexpression	BUSSLINGER_GASTRIC_PREZYMOGENIC_CELLS	TTC3 EGR1 SRRM2 MUC6	7.63e-05	60	98	4	M40007
Coexpression	DACOSTA_UV_RESPONSE_VIA_ERCC3_DN	HIVEP2 MAP1B PODXL DDR2 XPO1 SIK3 TRIM24 NFATC3 PRRC2C SIPA1L1 TMEM131L NUP153	8.43e-05	856	98	12	M4500
Coexpression	GSE41867_NAIVE_VS_DAY15_LCMV_ARMSTRONG_EFFECTOR_CD8_TCELL_DN	CASS4 SMG1 ZSWIM8 TBC1D9 SMCR8 AGAP3	1.05e-04	199	98	6	M9501
Coexpression	GSE2585_CTEC_VS_THYMIC_MACROPHAGE_DN	ZSWIM8 SETD1B TTC3 COG1 FGFR1 PLEC	1.05e-04	199	98	6	M6264
Coexpression	CAMP_UP.V1_DN	ARHGEF12 BCR ZCCHC14 ABLIM1 PHLDB1 TJP1	1.05e-04	199	98	6	M2719
Coexpression	GSE9988_LOW_LPS_VS_CTRL_TREATED_MONOCYTE_DN	SETD1B BAG4 SH2D3C CHD8 KLF13 OLIG1	1.08e-04	200	98	6	M5870
Coexpression	GSE14769_UNSTIM_VS_360MIN_LPS_BMDM_DN	HIVEP2 SETD1B FIGN WAC SIPA1L1 SCN5A	1.08e-04	200	98	6	M3510
Coexpression	MENON_FETAL_KIDNEY_4_PODOCYTES	PODXL ARHGEF12 CMYA5 TJP1 PRRC2C SRRM2	1.26e-04	206	98	6	M39254
Coexpression	HOSHIDA_LIVER_CANCER_SURVIVAL_UP	PODXL ABLIM1 LPP CTNND2	1.64e-04	73	98	4	M6939
Coexpression	AIZARANI_LIVER_C7_EPCAM_POS_BILE_DUCT_CELLS_2	SHROOM3 COL27A1 ABLIM1 EGR1 CTNND2 MUC6	1.76e-04	219	98	6	M39111
CoexpressionAtlas	DevelopingGonad_e18.5_ovary_emap-12283_k-means-cluster#2_top-relative-expression-ranked_1000	CHD8 SRCAP TRIM24 FRMD4B PRRC2C LPP PLEC NUP153 CDON	5.14e-07	210	97	9	gudmap_developingGonad_e18.5_ovary_1000_k2
CoexpressionAtlas	DevelopingGonad_e16.5_ovary_emap-9563_k-means-cluster#2_top-relative-expression-ranked_1000	SMG1 CHD8 SRCAP TRIM24 FRMD4B PRRC2C LPP PLEC CDON	1.10e-06	230	97	9	gudmap_developingGonad_e16.5_ovary_1000_k2
CoexpressionAtlas	FacebaseRNAseq_e10.5_Neural Epithelium Overlying Medial Eminence_top-relative-expression-ranked_2500_k-means-cluster#4	TCEA1 SMG1 MAP1B ARHGEF12 SRCAP TRIM24 FRMD4B WAC COG1 SIPA1L1 YLPM1 CTNND2	1.71e-05	595	97	12	Facebase_RNAseq_e10.5_Neural Epithelium Overlying Medial Eminence_2500_K4
CoexpressionAtlas	DevelopingGonad_e14.5_ ovary_emap-6699_k-means-cluster#3_top-relative-expression-ranked_1000	SMG1 CHD8 SRCAP TRIM24 FRMD4B LPP NUP153	7.82e-05	225	97	7	gudmap_developingGonad_e14.5_ ovary_1000_k3
ToppCell	Children_(3_yrs)-Endothelial-alveolar_capillary_endothelial_cell_(Cap2;_aerocyte)-D032\|Children_(3_yrs) / Lineage, Cell type, age group and donor	PODXL SH2D3C ARHGEF12 SORBS1 BCR ABLIM1 PHLDB1 FGD5	9.92e-09	190	98	8	0e9847d7f49b2236b8a191e1a7df37556351ba9e
ToppCell	(03)_KRT6B+-(2)_GFP_FOXI1\|(03)_KRT6B+ / shred by cell type by condition	TCEA1 TET2 SHROOM3 MAP1B BCLAF1 TTC3 PRRC2C LPP	1.42e-08	199	98	8	c425e7975f492ed5cfcca022248adb627e1d27d4
ToppCell	Children_(3_yrs)-Endothelial-alveolar_capillary_endothelial_cell_(Cap2;_aerocyte)\|Children_(3_yrs) / Lineage, Cell type, age group and donor	PODXL SH2D3C ARHGEF12 SORBS1 ABLIM1 PHLDB1 FGD5	2.22e-07	191	98	7	f229abf69a1217194f74b0502486907e07dba989
ToppCell	Children_(3_yrs)-Mesenchymal-matrix_fibroblast_2_cell-D032\|Children_(3_yrs) / Lineage, Cell type, age group and donor	DDR2 USP2 PHLDB1 EGR1 GLI2 FGFR1 CDON	2.56e-07	195	98	7	ff0aa455e9844a6d7ae57ff59fb6cea825cf1fc2
ToppCell	Smart-seq2-spleen_(Smart-seq2)-myeloid-myeloid_granulocytic-neutrophil\|spleen_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type	SHROOM3 MUC16 PLEKHA6 EGR1 SCN10A MUC3A CDON	2.56e-07	195	98	7	d3755929ebbbf5e3afde44281e9056ddb614a291
ToppCell	Smart-seq2-spleen_(Smart-seq2)-myeloid-myeloid_granulocytic\|spleen_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type	SHROOM3 MUC16 PLEKHA6 EGR1 SCN10A MUC3A CDON	2.56e-07	195	98	7	19853c654ac64b3ae3bc99841c6cb29c8aaba85c
ToppCell	COVID-19-lung-Capillary_Aerocytes\|lung / Disease (COVID-19 only), tissue and cell type	PODXL SH2D3C ARHGEF12 SORBS1 ABLIM1 TJP1 FGD5	2.65e-07	196	98	7	4ac4073380d939a73cec7413e9f3f5ef616d2924
ToppCell	COVID-19_Mild\|World / Disease condition and Cell class	TET2 SMG1 BCLAF1 ZCCHC2 EGR1 PRRC2C SRRM2	2.83e-07	198	98	7	61ceb2245b6cb58e308b999a61d218c89dbc615e
ToppCell	COPD-Myeloid-Macrophage\|Myeloid / Disease state, Lineage and Cell class	TET2 FRMD4B GRAMD4 TBC1D9 SIPA1L1 FGFR1 AGAP3	2.93e-07	199	98	7	1cf1b2d6debf9e3389f1829dcaa2857e9533a080
ToppCell	mild\|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class	TET2 SMG1 BCLAF1 XPO1 ZCCHC2 PRRC2C SRRM2	3.03e-07	200	98	7	12f1685ce8f218433068e090c9d839cd5a1910bf
ToppCell	Adult-Mesenchymal-chondrocyte-D175\|Adult / Lineage, Cell type, age group and donor	MAP1A MAP1B COL27A1 DDR2 TRPM3 GLI2	1.96e-06	168	98	6	14071b961c9bdb54a8259b12a88237b802cbde36
ToppCell	COVID-19-Heart-CM_+_Macrophage\|COVID-19 / Disease (COVID-19 only), tissue and cell type	SORBS1 CMYA5 C4orf54 SCN5A CTNND2 ALPK2	2.10e-06	170	98	6	3f15242a1d3e4e9871d9170b2ef05842fb609c29
ToppCell	E16.5-Endothelial-Endothelial_blood-vessel-Macrovascular_EC-AEC-AEC_prolif\|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	SIK3 CMYA5 TBC1D9 ZCCHC14 ABLIM1 FGD5	2.10e-06	170	98	6	55fe16d98ea284d05fb899888e4569c685644c7b
ToppCell	COVID-19-Heart-CM_3\|COVID-19 / Disease (COVID-19 only), tissue and cell type	SORBS1 CMYA5 C4orf54 SCN5A CTNND2 ALPK2	2.57e-06	176	98	6	9df7a124ebafb0087da0cda133a394275d7bed81
ToppCell	Children_(3_yrs)-Endothelial-alveolar_capillary_endothelial_cell_(Cap2;_aerocyte)-D046\|Children_(3_yrs) / Lineage, Cell type, age group and donor	PODXL SH2D3C SORBS1 ABLIM1 PHLDB1 FGD5	3.12e-06	182	98	6	a20017b6a4f9a6a29e090e4dbd7c02ed1495bd50
ToppCell	COVID-19-kidney-PCT-S1\|kidney / Disease (COVID-19 only), tissue and cell type	COL27A1 FIGN FRMD4B TRPM3 PAX8 ALPK2	3.32e-06	184	98	6	51ed1ebfdef45149541917c66cbacad87072e51f
ToppCell	renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	MAP1B DDR2 SORBS1 FIGN ADGRG4 GLI2	3.32e-06	184	98	6	e061e85c4bb19f49f6451ddd7a9077d7378ee365
ToppCell	COVID-19-Heart-CM_2\|COVID-19 / Disease (COVID-19 only), tissue and cell type	SORBS1 CMYA5 ABLIM1 SCN5A CTNND2 ALPK2	3.43e-06	185	98	6	549eeb521c3985bff396ea0f202db21822efa51f
ToppCell	renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Proximal_Tubule_Epithelial_Cell_Segment_3\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	FRMD4B GRAMD4 ABLIM1 TRPM3 PAX8 ALPK2	3.54e-06	186	98	6	b1edc341d6684b347dc9e21b34f62f51d095d735
ToppCell	Adult-Endothelial-alveolar_capillary_endothelial_cell_(Cap2;_aerocyte)\|Adult / Lineage, Cell type, age group and donor	PODXL SH2D3C SORBS1 ABLIM1 PHLDB1 FGD5	3.76e-06	188	98	6	e5cad03f4a64147fe8174e7f614cf45233ffb9b7
ToppCell	renal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast-\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	MAP1B DDR2 SORBS1 GLI2 FGFR1 NUP153	4.00e-06	190	98	6	1121eb607a984c59fbffe7220837fc178745aa55
ToppCell	RV-15._Ventricular_Cardiomyocyte_III\|RV / Chamber and Cluster_Paper	ARHGEF12 SORBS1 SIK3 CMYA5 ABLIM1 ALPK2	4.00e-06	190	98	6	93c3188dfeb0b2f9889f8ae9b9c1f2f34129c99b
ToppCell	COVID-19-Heart\|COVID-19 / Disease (COVID-19 only), tissue and cell type	MAP1B SORBS1 CMYA5 ABLIM1 SCN5A CTNND2	4.00e-06	190	98	6	918ad5037881212008f9f69d5df5da91fd01422c
ToppCell	renal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	MAP1B DDR2 SORBS1 GLI2 FGFR1 NUP153	4.00e-06	190	98	6	048b581e3f7ea9fc2f87c0532974bba85c7292c2
ToppCell	renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast-Adaptive_/_Maladaptive_/_Repairing_Fibroblast\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	MAP1B DDR2 SORBS1 ADGRG4 EGR1 FGFR1	4.12e-06	191	98	6	2c51850f5c559d665b8a27a12b75af9ed58dffe1
ToppCell	LA-03._Atrial_Cardiomyocyte\|LA / Chamber and Cluster_Paper	SORBS1 CMYA5 ABLIM1 SCN5A CTNND2 ALPK2	4.12e-06	191	98	6	5d1b674eb7703830b7ce8bbeac3363cabd0e6ae9
ToppCell	COVID-19-Heart-EC_(POSTN)\|Heart / Disease (COVID-19 only), tissue and cell type	PODXL BCR FRMD4B TRPM3 SIPA1L1 FGD5	4.24e-06	192	98	6	c0c34785a7bdf461722029b322e9184e3d9b3c26
ToppCell	LPS-antiTNF-Endothelial-Endothelial-Activated_Alv_Cap\|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	PODXL SH2D3C ARHGEF12 TJP1 FGD5 CTNND2	4.24e-06	192	98	6	c618ede75dce3988c87a5b8f98d8e94e1dd66efd
ToppCell	renal_medulla_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	MAP1B SORBS1 FIGN GLI2 LPP TMEM131L	4.24e-06	192	98	6	24e2f15f5767a97eb3b389922bcfd7b13805e1ce
ToppCell	Endothelial-alveolar_capillary_endothelial_cell_(Cap2;_aerocyte)\|World / Lineage, Cell type, age group and donor	PODXL SH2D3C SORBS1 ABLIM1 PHLDB1 FGD5	4.24e-06	192	98	6	1e156bab5ecf64627890d2de9b27603d9a01f28d
ToppCell	Fetal_29-31_weeks-Endothelial-alveolar_capillary_endothelial_cell_(Cap2;_aerocyte)-D150\|Fetal_29-31_weeks / Lineage, Cell type, age group and donor	PODXL SH2D3C SORBS1 TRIM24 PHLDB1 FGD5	4.24e-06	192	98	6	7197e401e563441ab94815f7619e032ebef9e586
ToppCell	COVID-19-Heart-CM_+_EC_+_Pericyte\|Heart / Disease (COVID-19 only), tissue and cell type	SORBS1 CMYA5 ABLIM1 SCN5A CTNND2 ALPK2	4.37e-06	193	98	6	dd5378a1ef8eb0eda9a3aae62f3c2f3a1402bda0
ToppCell	LPS-antiTNF-Endothelial-Endothelial\|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	PODXL SH2D3C ARHGEF12 TJP1 FGD5 CTNND2	4.37e-06	193	98	6	02f633b016ab19bfa65bfd0cf32f000549a62148
ToppCell	LPS-antiTNF-Endothelial\|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	PODXL SH2D3C ARHGEF12 TJP1 FGD5 CTNND2	4.37e-06	193	98	6	5122b1ffba42de190061be34ecdc6176f84e56a3
ToppCell	renal_cortex_nuclei-Adult_normal_reference-Epithelial\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	SHROOM3 PLEKHA6 CMYA5 ABLIM1 TRPM3 PAX8	4.37e-06	193	98	6	3866667dd221612589ae50f5c52f73a183a49ce6
ToppCell	LPS-IL1RA-Endothelial-Endothelial-Activated_Alv_Cap\|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	PODXL SH2D3C ARHGEF12 SORBS1 TJP1 FGD5	4.37e-06	193	98	6	a3636c35ed25aabe2f1aba016c9fe125327bbfaf
ToppCell	droplet-Limb_Muscle-MUSCLE-30m-Mesenchymal-skeletal_muscle_satellite_cell\|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	MAP1B VGLL2 TTC3 PRRC2C SCN5A SRRM2	4.37e-06	193	98	6	1aa3ab528605dc7b2fec46e759c9d1ee93d59b11
ToppCell	renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	SHROOM3 PLEKHA6 CMYA5 ABLIM1 ZNF827 PAX8	4.50e-06	194	98	6	7002937e8903e037332a215d00fbc7c7843b33f2
ToppCell	LPS-IL1RA-Endothelial\|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	PODXL SH2D3C ARHGEF12 TJP1 FGD5 CTNND2	4.50e-06	194	98	6	43f92b0533e26633dc94cce554045d641ef8fd76
ToppCell	LPS-IL1RA-Endothelial-Endothelial\|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	PODXL SH2D3C ARHGEF12 TJP1 FGD5 CTNND2	4.50e-06	194	98	6	1d39d968730a7e85b6161c1c8a6bd38afe9bcad7
ToppCell	5'-Adult-SmallIntestine-Epithelial-Tuft-related\|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract	SHROOM3 CMYA5 ADGRG4 MUC3A POU2F3 MUC6	4.64e-06	195	98	6	23ab7e2a419377c05bab0e92a2457afbcd3d9e07
ToppCell	COVID-19-Heart-CM_2\|Heart / Disease (COVID-19 only), tissue and cell type	SORBS1 CMYA5 ABLIM1 SCN5A CTNND2 ALPK2	4.64e-06	195	98	6	75fc81bddb246dca3b437fb60827b1d4fe416405
ToppCell	renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	MAP1B DDR2 SORBS1 FIGN GLI2 TMEM131L	4.64e-06	195	98	6	edd4cd8402af81737b2074f9dce71cc6ab09be7e
ToppCell	COVID-19-kidney-Fibroblast-2\|COVID-19 / Disease (COVID-19 only), tissue and cell type	MAP1B COL27A1 DDR2 SORBS1 FIGN GLI2	4.64e-06	195	98	6	3d62ce1c696f47d4d7eb0c5bb0eec2c24b122bb2
ToppCell	facs-Lung-3m\|Lung / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	TET2 NR1D1 ALKBH5 EGR1 PRRC2C FGFR1	4.64e-06	195	98	6	c4648c0332c3826776f9ad3f5f803dbac2b4c0c0
ToppCell	droplet-Limb_Muscle-MUSCLE-30m-Mesenchymal\|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	MAP1B BCLAF1 CMYA5 EGR1 PRRC2C SRRM2	4.64e-06	195	98	6	5c86fddd6d0530beecf45ea5ba6b823123847696
ToppCell	Fetal_29-31_weeks-Mesenchymal-matrix_fibroblast_2_cell-D062\|Fetal_29-31_weeks / Lineage, Cell type, age group and donor	MAP1B DDR2 FIGN ZNF469 PHLDB1 GLI2	4.78e-06	196	98	6	525d6c8a277364e624e7cc586275f8a891436b57
ToppCell	COVID-19-lung-Capillary_Aerocytes\|COVID-19 / Disease (COVID-19 only), tissue and cell type	PODXL SH2D3C ARHGEF12 SORBS1 TJP1 FGD5	4.78e-06	196	98	6	49cc0a2b9739abad61dff7292ea0b14d28ff35c4
ToppCell	Non-neuronal-Non-dividing-Radial_Glia-tRG\|World / Primary Cells by Cluster	SHROOM3 COL27A1 DDR2 EGR1 LPP CDON	4.92e-06	197	98	6	61749ccafeb938c310cff1de5ff924a1c794325a
ToppCell	Non-neuronal-Non-dividing-Radial_Glia-tRG-25\|World / Primary Cells by Cluster	SHROOM3 COL27A1 DDR2 EGR1 LPP CDON	4.92e-06	197	98	6	9d4ffa3680f92c91d0a081f9a8ec5ebfec6bdcf6
ToppCell	renal_cortex_nuclei-Adult_normal_reference-Mesenchymal\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	MAP1B DDR2 SORBS1 FIGN GLI2 TMEM131L	5.06e-06	198	98	6	79576525a10ed3e3a9d1608077cd16ecda23376f
ToppCell	Bronchial-10x5prime-Stromal-Fibroblastic-Fibro_myofibroblast\|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations	MAP1A MAP1B DDR2 FIGN ZNF469 GLI2	5.21e-06	199	98	6	21335475bbfbad8a6943b8076a6c1c67f3eec5d3
ToppCell	MS-IIF-Lymphocyte-T/NK-dn_T\|IIF / Disease, condition lineage and cell class	DDR2 MUC12 ZCCHC14 NFATC3 CUZD1 FGFR1	5.36e-06	200	98	6	c34fff02992cba6bcc2308019cb00b94e1227300
ToppCell	facs-Brain_Non-Myeloid-Hippocampus-24m-Macroglial\|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation	MAP1A SLC26A9 FIGN PHLDB1 OLIG1	1.36e-05	138	98	5	c1a46fbf1beffa12c3d1b78361e0613e2e9e2d13
ToppCell	facs-Brain_Non-Myeloid-Hippocampus-24m-Macroglial-nan\|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation	MAP1A ZBTB22 SLC26A9 PHLDB1 OLIG1	1.57e-05	142	98	5	67d4ff3483ae34f77c3325aa0fbd3462ca19ade4
ToppCell	facs-Brain_Non-Myeloid-Hippocampus-24m-Macroglial-oligodendrocyte\|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation	MAP1A ZBTB22 SLC26A9 FIGN PHLDB1	2.04e-05	150	98	5	afd651c654e715414eff64cf3a37378d057a56a2
ToppCell	Adult-Endothelial-alveolar_capillary_endothelial_cell_(Cap2;_aerocyte)-D231\|Adult / Lineage, Cell type, age group and donor	PODXL SH2D3C SORBS1 PHLDB1 FGD5	3.41e-05	167	98	5	5af9127bae05768a5164d5708a4ad37edca99324
ToppCell	5'-Adult-SmallIntestine-Epithelial-Tuft-related-Tuft\|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract	TET2 CIART COL27A1 CMYA5 POU2F3	3.51e-05	168	98	5	8072d0496b7b730c4601009eaa69ec5366d26d73
ToppCell	facs-Limb_Muscle-forelimb_and_hindlimb-18m-Lymphocytic-T_cell\|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ZCCHC2 GRAMD4 WAC ABLIM1 TMEM131L	3.51e-05	168	98	5	182f08106ac65ea501e2fb9139d3b44b7c4662c9
ToppCell	facs-Skin-Skin_Anagen-18m-Lymphocytic-T_cell\|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CASS4 COL27A1 FGD5 CTNND2 ALPK2	3.61e-05	169	98	5	630d921aa8fb5681d06a4e09b833855c374be484
ToppCell	facs-Skin-Skin_Anagen-18m-Lymphocytic-nan\|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CASS4 COL27A1 FGD5 CTNND2 ALPK2	3.61e-05	169	98	5	468284d4a3a0557aed04eadb1aba2317babc6904
ToppCell	facs-Skin-Skin_Anagen-18m-Lymphocytic\|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CASS4 COL27A1 FGD5 CTNND2 ALPK2	3.61e-05	169	98	5	6f765e142d127545e622fe24b5287cd6e9706ccc
ToppCell	Adult-Endothelial-alveolar_capillary_endothelial_cell_(Cap2;_aerocyte)-D122\|Adult / Lineage, Cell type, age group and donor	PODXL SH2D3C SORBS1 PHLDB1 FGD5	3.82e-05	171	98	5	bd20e85d36fa9d7ddc8afef6a1dea75efc9ee1dc
ToppCell	facs-Brain_Myeloid-Cerebellum-3m-Myeloid-nan\|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation	TET2 SMG1 EGR1 ZNF827 PRRC2C	4.03e-05	173	98	5	869da6a65d1b9b7529c666ec44e3c8ddec2ea408
ToppCell	CV-Mild-7\|Mild / Virus stimulation, Condition and Cluster	TET2 ZCCHC14 COG1 CABIN1 ALPK2	4.03e-05	173	98	5	c9bbca9313a0fdf146c8c995624b94b937e818d8
ToppCell	facs-Brain_Myeloid-Cerebellum-3m-Myeloid\|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation	TET2 SMG1 EGR1 ZNF827 PRRC2C	4.03e-05	173	98	5	0672bd8a4a9d18af343d01f09253fb3388896c10
ToppCell	facs-Brain_Myeloid-Cerebellum-3m\|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation	TET2 SMG1 EGR1 ZNF827 PRRC2C	4.03e-05	173	98	5	870e091ec30be01a900e1cb8b9ef1880e3b7b50d
ToppCell	facs-Brain_Myeloid-Cerebellum-3m-Myeloid-microglial_cell\|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation	TET2 SMG1 EGR1 ZNF827 PRRC2C	4.26e-05	175	98	5	1ea6cf9da26601646f57fa14d558a5e9e1f0b345
ToppCell	10x_3'_v2v3-Neoplastic-Differentiated-like-MES-like-MES-like_hypoxia/MHC-B\|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	MAP1B PODXL SORBS1 FGFR1 CTNND2	4.26e-05	175	98	5	e99e145a152f534b75267ec492a252a0b814b4f8
ToppCell	human_hepatoblastoma-Tumor_cells-T6\|Tumor_cells / Sample and Cell Type and Tumor Cluster (all cells)	CASS4 TET2 HIVEP2 TRPM3 FGFR1	4.75e-05	179	98	5	14fc8ccb6b215063d747643f47d780d2b237eb67
ToppCell	Control-Stromal_mesenchymal-Matrix_Fibroblast-MatrixFB\|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	COL27A1 DDR2 PLEKHA6 TTC8 GLI2	4.87e-05	180	98	5	08ae0f5d95c45feba68ad99788f7af7ff4c979af
ToppCell	Control-Endothelial_cells-Capillary_endothelial_cells\|Control / group, cell type (main and fine annotations)	PODXL SH2D3C SORBS1 PHLDB1 FGD5	4.87e-05	180	98	5	b043f9ffb9a4cd427a15bebb86a711c7b08866e8
ToppCell	COVID-19-kidney-PCT-S2\|COVID-19 / Disease (COVID-19 only), tissue and cell type	COL27A1 PLEKHA6 TRPM3 PAX8 ALPK2	4.87e-05	180	98	5	358923e4228035a3e90e2957392089219e90dcd7
ToppCell	Fetal_29-31_weeks-Endothelial-alveolar_capillary_endothelial_cell_(Cap2;_aerocyte)-D088\|Fetal_29-31_weeks / Lineage, Cell type, age group and donor	PODXL SH2D3C SORBS1 ABLIM1 FGD5	4.87e-05	180	98	5	d8ef44710a77ad0fc03243428e5e1dc4d41200cb
ToppCell	LPS-antiTNF-Endothelial-Endothelial-Alv_Cap\|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	PODXL SH2D3C TJP1 FGD5 CTNND2	4.87e-05	180	98	5	30cf3c7ee29694eaccb89bf8053a82037d5c9f1d
ToppCell	COVID-19-Endothelial_cells-Endothelial_cells_(other)\|COVID-19 / group, cell type (main and fine annotations)	PODXL ARHGEF12 SORBS1 ABLIM1 FGD5	5.00e-05	181	98	5	26eb4ee57a70dbf54e096b73129fda9dfda1f6ec
ToppCell	droplet-Thymus-nan-24m-Lymphocytic-DN3_thymocyte\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	LCA5 BCR FRMD4B PHLDB1 ZBTB3	5.00e-05	181	98	5	e2d03115a87f45a7ddd3ade6b9ac3843639bd41a
ToppCell	COVID-19-Endothelial_cells-Capillary_endothelial_cells\|COVID-19 / group, cell type (main and fine annotations)	PODXL SH2D3C ARHGEF12 SORBS1 FGD5	5.00e-05	181	98	5	c5f9c92af1384d9089c65afdf41c6feb8345a3ae
ToppCell	droplet-Thymus-nan-24m-Lymphocytic-Double_negative_thymocyte,_DN3_(Cd8-,_Cd4-),_some_express_pre_TCR_alpha\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	LCA5 BCR FRMD4B PHLDB1 ZBTB3	5.00e-05	181	98	5	d8d11ef83c4b8b6a6f5c8728e03059e45a8ad264
ToppCell	COVID-19-Heart-CM_+_EC_+_Pericyte\|COVID-19 / Disease (COVID-19 only), tissue and cell type	SORBS1 CMYA5 SCN5A CTNND2 ALPK2	5.00e-05	181	98	5	719eb532453ab7cd7893726885bc75d74a10b21e
ToppCell	COVID-19-Heart-CM_3\|Heart / Disease (COVID-19 only), tissue and cell type	SORBS1 CMYA5 C4orf54 CTNND2 ALPK2	5.13e-05	182	98	5	287fcc3897ae08841f6f85ae6c9cef16f75b1dd1
ToppCell	COVID-19-kidney-PCT-S1\|COVID-19 / Disease (COVID-19 only), tissue and cell type	COL27A1 PLEKHA6 TRPM3 PAX8 ALPK2	5.27e-05	183	98	5	6878d14026c3df6aa12e45dfad94b32fa9d9b0b7
ToppCell	facs-Limb_Muscle-ForelimbandHindlimb-24m-Mesenchymal-skeletal_muscle_satellite_cell\|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	MAP1B VGLL2 USP2 EMD SRRM2	5.27e-05	183	98	5	7534587fa35837c0aaca93c542f2eee493eba637
ToppCell	Control-Epithelial_alveolar-AT_2-Differentiating_AT2\|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	SHROOM3 FIGN TRIM24 TRPM3 CDON	5.55e-05	185	98	5	0d2add28ac1f4fa6de7699be009bf8391badaf4c
ToppCell	COVID-19-kidney-Mito-rich_PCT\|COVID-19 / Disease (COVID-19 only), tissue and cell type	COL27A1 PLEKHA6 TRPM3 PAX8 ALPK2	5.55e-05	185	98	5	1bbc2ba8a20f72f61981b1301cdd6018cdd9150d
ToppCell	Fetal_29-31_weeks-Mesenchymal-airway_smooth_muscle_cell-D088\|Fetal_29-31_weeks / Lineage, Cell type, age group and donor	SORBS1 PHLDB1 GLI2 LPP FGFR1	5.55e-05	185	98	5	e58a009aaf342be019a909747b1895d5987d4daf
ToppCell	Control-Endothelial-VE_Capillary_A\|World / Disease state, Lineage and Cell class	PODXL SH2D3C ARHGEF12 SORBS1 PHLDB1	5.55e-05	185	98	5	a28187c2fd23564314b35759479ff2ca21f61485
ToppCell	Smart-seq2-blood_(Smart-seq2)-myeloid-myeloid_monocytic-classical_monocyte\|blood_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type	MUC16 EGR1 PRRC2C SCN10A PLEC	5.69e-05	186	98	5	23b8d51d20b05795a73892d3e20e0f9b6a207820
ToppCell	Control-Endothelial_cells-Endothelial_cells_(other)\|Control / group, cell type (main and fine annotations)	PODXL SH2D3C SORBS1 PHLDB1 FGD5	5.69e-05	186	98	5	c6075fe84226b370c5139066793844ad33ae2db1
ToppCell	renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Proximal_Tubule_Epithelial_Cell_Segment_1_/_Segment_2\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	PLEKHA6 FRMD4B USP2 TRPM3 PAX8	5.69e-05	186	98	5	5784d255e9ca449d375d81938d0fbbd8a7eb44f6
ToppCell	primary_visual_cortex-Non-neuronal-oligodendrocyte-Oligo-Oligo_Rassf10\|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype	FIGN PHLDB1 OLIG1 MUC3A	5.79e-05	95	98	4	0ac6cba7e0ed6083f777287f39a871461fa1bca4
ToppCell	renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Degenerative_Proximal_Tubule_Epithelial_Cell\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	PLEKHA6 ABLIM1 TRPM3 ZNF827 PAX8	5.84e-05	187	98	5	3ae3b8de1a195d4d5057cf3c64fcdb5f48681ce5
ToppCell	COVID-19-kidney-tDL\|kidney / Disease (COVID-19 only), tissue and cell type	COL27A1 FIGN TRPM3 PAX8 ALPK2	5.84e-05	187	98	5	d35d27ca3c0e65f92f4508e1cb98a743f44fdcdf
ToppCell	renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Proximal_Tubule_Epithelial_Cell\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	COL27A1 FIGN TRPM3 PAX8 ALPK2	5.84e-05	187	98	5	9d77ca45f7563bd6f2a0c1be5d99d93ad30983f7
ToppCell	Control-Endothelial-VE_Capillary_A\|Control / Disease state, Lineage and Cell class	PODXL SH2D3C ARHGEF12 SORBS1 PHLDB1	5.84e-05	187	98	5	54d7588172ac145ff5045ad9771636729ca3f0ca
ToppCell	LA-03._Atrial_Cardiomyocyte\|World / Chamber and Cluster_Paper	SORBS1 CMYA5 SCN5A CTNND2 ALPK2	5.99e-05	188	98	5	6d249fe92d51a19da19ec14bb2262d394255d577
ToppCell	10x5'-GI_small-bowel-Lymphocytic_T_CD4-T_CD4/CD8\|GI_small-bowel / Manually curated celltypes from each tissue	SMG1 BCLAF1 SIK3 LPP TMEM131L	5.99e-05	188	98	5	ab9b725d6e0cdab8e9ddda6dee09e14730e9a578
ToppCell	renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	MAP1B DDR2 SORBS1 GLI2 TMEM131L	5.99e-05	188	98	5	b2d68a32314e9b099ed74d974079ad96359d1ae3
ToppCell	LPS-IL1RA+antiTNF-Endothelial-Endothelial-Alv_Cap\|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	PODXL SH2D3C TJP1 FGD5 CTNND2	5.99e-05	188	98	5	73f6ec915934154f435a376cb274b058ff7c5f35
ToppCell	droplet-Tongue-nan\|Tongue / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	MAP1B WAC EGR1 PRRC2C SRRM2	5.99e-05	188	98	5	d62cc37e86b7b186e53aeb7f421c4e5ee28f23bd
Drug	exemestane; Up 200; 0.01uM; MCF7; HG-U133A	SETD1B PODXL SRCAP NR1D1 EGR1 YLPM1 CUZD1 SCN10A FGFR1	1.83e-07	199	97	9	165_UP
Drug	Methylene Chloride	CUX2 HIVEP2 ZBTB22 ZCCHC2 NR1D1 KLF13 EGR1 NFATC3	4.89e-07	163	97	8	ctd:D008752
Drug	Metrizamide [31112-62-6]; Up 200; 5uM; MCF7; HT_HG-U133A	CASS4 MAP1A OR7C1 SRCAP PHLDB1 MEGF8 EGR1 PAX8	2.04e-06	197	97	8	4156_UP
Drug	Ascorbic acid [50-81-7]; Up 200; 22.4uM; PC3; HT_HG-U133A	FXR2 NR1D1 BCR PHLDB1 EGR1 NFATC3 CUZD1 FGFR1	2.04e-06	197	97	8	6306_UP
Drug	Ethisterone [434-03-7]; Up 200; 12.8uM; MCF7; HT_HG-U133A	MAP1A SRCAP USP2 NFATC3 GLI2 CUZD1 TMEM209 POU2F3	2.12e-06	198	97	8	2326_UP
Drug	aspirin, USP; Up 200; 100uM; PC3; HT_HG-U133A	CASS4 SRCAP MEGF8 KLF13 GLI2 CTNND2 SRRM2 CDON	2.12e-06	198	97	8	4428_UP
Drug	Diphenylpyraline hydrochloride [132-18-3]; Down 200; 12.6uM; MCF7; HT_HG-U133A	ARHGEF12 PLEKHA6 NR1D1 PHLDB1 CUZD1 FGFR1 SRRM2 CDON	2.20e-06	199	97	8	3640_DN
Drug	clotrimazole; Up 200; 50uM; MCF7; HT_HG-U133A_EA	WIPI1 MAP1B SRCAP TBC1D9 EGR1 NFATC3 SIPA1L1	1.45e-05	185	97	7	905_UP
Drug	Clioquinol [130-26-7]; Up 200; 13uM; MCF7; HT_HG-U133A	MAP1B SRCAP NR1D1 FRMD4B TRPM3 EGR1 FGFR1	1.72e-05	190	97	7	5623_UP
Drug	Hexylcaine	SCN5A SCN10A	1.80e-05	2	97	2	DB00473
Drug	Graveoline [485-61-0]; Down 200; 14.4uM; MCF7; HT_HG-U133A	HIVEP2 BAG4 ARHGEF12 PLEKHA6 FRMD4B CUZD1 FGFR1	1.90e-05	193	97	7	3614_DN
Drug	0173570-0000 [211245-44-2]; Up 200; 10uM; MCF7; HT_HG-U133A	SRCAP PHLDB1 EGR1 PAX8 SCN10A FGFR1 MUC6	1.90e-05	193	97	7	4712_UP
Drug	Acetylsalicylsalicylic acid [530-75-6]; Down 200; 13.4uM; MCF7; HT_HG-U133A	FXR2 BAG4 ACAD10 PLEKHA6 SRCAP FGFR1 CABIN1	1.97e-05	194	97	7	6778_DN
Drug	Flutamide [13311-84-7]; Down 200; 14.4uM; MCF7; HT_HG-U133A	FXR2 ABLIM1 PRRC2C LPP CUZD1 TMEM209 SRRM2	1.97e-05	194	97	7	4361_DN
Drug	haloperidol; Up 200; 10uM; MCF7; HT_HG-U133A	HIVEP2 KLF13 NFATC3 SCN10A TMEM209 FGFR1 CDON	2.03e-05	195	97	7	5241_UP
Drug	Protriptyline hydrochloride [1225-55-4]; Down 200; 13.4uM; PC3; HT_HG-U133A	FXR2 NR1D1 GLI2 YLPM1 FGFR1 CABIN1 SRRM2	2.03e-05	195	97	7	6338_DN
Drug	sodium 4-phenylbutyrate; Up 200; 100uM; HL60; HG-U133A	ZSWIM8 LPP SCN5A YLPM1 FGFR1 EMD PLEC	2.10e-05	196	97	7	363_UP
Drug	clozapine; Up 200; 10uM; MCF7; HT_HG-U133A	WIPI1 ARHGEF12 USP2 PHLDB1 SIPA1L1 LPP CDON	2.10e-05	196	97	7	5226_UP
Drug	Methotrexate [59-05-2]; Up 200; 8.8uM; PC3; HT_HG-U133A	WIPI1 ARHGEF12 PHLDB1 KLF13 EGR1 CUZD1 TMEM209	2.10e-05	196	97	7	6318_UP
Drug	Iopanoic acid [96-83-3]; Down 200; 7uM; PC3; HT_HG-U133A	FXR2 NFATC3 YLPM1 TMEM209 EMD CABIN1 SRRM2	2.10e-05	196	97	7	6348_DN
Drug	estradiol, USP; Up 200; 0.1uM; MCF7; HT_HG-U133A	MAP1A PLEKHA6 NR1D1 USP2 GLI2 FGFR1 CDON	2.10e-05	196	97	7	6928_UP
Drug	Bromocryptine mesylate [22260-51-1]; Down 200; 5.4uM; PC3; HT_HG-U133A	HIVEP2 CHD8 KLF13 NFATC3 PLEC CTNND2 SRRM2	2.17e-05	197	97	7	4604_DN
Drug	genistein; Up 200; 10uM; MCF7; HT_HG-U133A	WIPI1 HIVEP2 BCR KLF13 LPP CUZD1 CTNND2	2.17e-05	197	97	7	6952_UP
Drug	troglitazone; Down 200; 10uM; MCF7; HT_HG-U133A	NR1D1 ZCCHC14 PHLDB1 NFATC3 CUZD1 PLEC CABIN1	2.17e-05	197	97	7	5592_DN
Drug	Hydroxytacrine maleate (R,S) [118909-22-1]; Up 200; 12.2uM; PC3; HT_HG-U133A	MAP1A SORBS1 ZCCHC14 PHLDB1 KLF13 PAX8 POU2F3	2.24e-05	198	97	7	6651_UP
Drug	Streptomycin sulfate [3810-74-0]; Up 200; 2.8uM; PC3; HT_HG-U133A	BCR GRAMD4 ZCCHC14 GLI2 FGFR1 MUC6 CDON	2.24e-05	198	97	7	5837_UP
Drug	Ticlopidine hydrochloride [53885-35-1]; Down 200; 13.4uM; PC3; HT_HG-U133A	SETD1B ARHGEF12 ACAD10 PLEKHA6 ZCCHC2 TBC1D9 TMEM209	2.24e-05	198	97	7	4074_DN
Drug	Oxybenzone [131-57-7]; Up 200; 17.6uM; MCF7; HT_HG-U133A	PHLDB1 MEGF8 KLF13 PAX8 CUZD1 SCN10A PLEC	2.32e-05	199	97	7	6469_UP
Drug	Vancomycin hydrochloride [1404-93-9]; Down 200; 2.6uM; MCF7; HT_HG-U133A	ZSWIM8 ACAD10 SRCAP LPP FGFR1 PLEC CTNND2	2.32e-05	199	97	7	2858_DN
Drug	Acetazolamide [59-66-5]; Down 200; 18uM; PC3; HT_HG-U133A	HIVEP2 SRCAP BCR GRAMD4 TBC1D9 YLPM1 SRRM2	2.32e-05	199	97	7	1808_DN
Drug	Doxepin hydrochloride [1229-29-4]; Down 200; 12.6uM; PC3; HT_HG-U133A	HIVEP2 FXR2 NFATC3 SIPA1L1 YLPM1 TMEM209 CABIN1	2.32e-05	199	97	7	6337_DN
Drug	Omeprazole [73590-58-6]; Up 200; 11.6uM; PC3; HT_HG-U133A	CASS4 OR7C1 SRCAP TRPM3 EGR1 SCN10A MUC6	2.39e-05	200	97	7	6606_UP
Drug	Aminophylline [317-34-0]; Down 200; 9.6uM; HL60; HT_HG-U133A	CASS4 HIVEP2 NR1D1 TBC1D9 SIPA1L1 YLPM1 FGFR1	2.39e-05	200	97	7	3036_DN
Drug	testosterone enanthate	SMG1 HIVEP2 FXR2 BCLAF1 CHD8 SORBS1 TTC3 USP2 PRRC2C EMD SRRM2	3.38e-05	575	97	11	ctd:C004648
Drug	Dibucaine	SCN5A SCN10A	5.37e-05	3	97	2	DB00527
Drug	rottlerin; Up 200; 10uM; MCF7; HT_HG-U133A_EA	WIPI1 MAP1B SRCAP NR1D1 EGR1 LPP	8.94e-05	170	97	6	941_UP
Drug	SAHA; Up 200; 10uM; MCF7; HT_HG-U133A	WIPI1 MAP1A MAP1B SORBS1 USP2 EGR1	9.54e-05	172	97	6	5217_UP
Drug	Trichostatin A, from Streptomyces sp.; Up 200; 0.1uM; MCF7; HT_HG-U133A	WIPI1 MAP1A MAP1B FRMD4B USP2 MEGF8	9.84e-05	173	97	6	5625_UP
Drug	Lidocaine	SCN5A SCN10A	1.07e-04	4	97	2	DB00281
Drug	Cycloheximide [66-81-9]; Up 200; 14.2uM; MCF7; HT_HG-U133A	HIVEP2 MAP1A SRCAP NR1D1 USP2 EGR1	1.15e-04	178	97	6	6220_UP
Drug	Trichostatin A, from Streptomyces sp.; Up 200; 0.1uM; MCF7; HT_HG-U133A	WIPI1 MAP1A MAP1B SORBS1 FRMD4B EGR1	1.22e-04	180	97	6	6064_UP
Drug	Camptothecine (S,+) [7689-03-4]; Down 200; 11.4uM; MCF7; HT_HG-U133A	ZCCHC2 TRIM24 WAC TMEM131L TNFRSF1A NUP153	1.30e-04	182	97	6	3887_DN
Drug	trifluoperazine dihydrochloride; Up 200; 10uM; MCF7; HT_HG-U133A	WIPI1 MAP1B PLEKHA6 SRCAP EGR1 CDON	1.34e-04	183	97	6	5221_UP
Drug	0179445-0000 [211246-22-9]; Up 200; 10uM; MCF7; HT_HG-U133A	CASS4 SRCAP USP2 KLF13 SCN10A SRRM2	1.38e-04	184	97	6	4755_UP
Drug	Nocodazole [31430-18-9]; Up 200; 13.2uM; MCF7; HT_HG-U133A	ZSWIM8 MAP1B ARHGEF12 SIPA1L1 LPP SCN10A	1.46e-04	186	97	6	6793_UP
Drug	Lansoprazole [103577-45-3]; Down 200; 10.8uM; HL60; HT_HG-U133A	HIVEP2 GRAMD4 EGR1 PAX8 LPP FGFR1	1.60e-04	189	97	6	2967_DN
Drug	Securinine [5610-40-2]; Down 200; 18.4uM; MCF7; HT_HG-U133A	HIVEP2 PODXL PHLDB1 YLPM1 FGFR1 PLEC	1.60e-04	189	97	6	6831_DN
Drug	Tolbutamide [64-77-7]; Down 200; 14.8uM; MCF7; HT_HG-U133A	FXR2 ZCCHC14 ABLIM1 NFATC3 TMEM209 SRRM2	1.64e-04	190	97	6	4362_DN
Drug	Phenformin hydrochloride [834-28-6]; Down 200; 16.6uM; PC3; HT_HG-U133A	MAP1B ABLIM1 KLF13 PRRC2C LPP TMEM209	1.69e-04	191	97	6	4283_DN
Drug	haloperidol; Down 200; 10uM; MCF7; HT_HG-U133A	CHD8 SIPA1L1 LPP FGFR1 PLEC CABIN1	1.69e-04	191	97	6	5200_DN
Drug	11-deoxy-16,16-dimethyl Prostaglandin E2; Up 200; 10uM; PC3; HT_HG-U133A	FXR2 GRAMD4 USP2 KLF13 LPP ZBTB3	1.69e-04	191	97	6	7538_UP
Drug	Bupivacaine hydrochloride [18010-40-7]; Down 200; 12.4uM; MCF7; HT_HG-U133A	MAP1B FXR2 SRCAP YLPM1 FGFR1 SRRM2	1.69e-04	191	97	6	7435_DN
Drug	estradiol, USP; Up 200; 0.01uM; MCF7; HT_HG-U133A	SETD1B USP2 NFATC3 SCN10A FGFR1 CDON	1.74e-04	192	97	6	5238_UP
Drug	Nitrendipine [39562-70-4]; Up 200; 11uM; HL60; HT_HG-U133A	CASS4 SIPA1L1 SCN5A FGFR1 MUC6 CDON	1.74e-04	192	97	6	3087_UP
Drug	Chlorhexidine [55-56-1]; Up 200; 8uM; MCF7; HT_HG-U133A	ZSWIM8 OR7C1 FXR2 FRMD4B EGR1 SCN10A	1.74e-04	192	97	6	1525_UP
Drug	troglitazone; Up 200; 10uM; MCF7; HT_HG-U133A	WIPI1 MAP1B EGR1 NFATC3 YLPM1 CUZD1	1.79e-04	193	97	6	6949_UP
Drug	Dizocilpine maleate [77086-22-7]; Up 200; 11.8uM; MCF7; HT_HG-U133A	MAP1A FXR2 ARHGEF12 CHD8 USP2 SRRM2	1.79e-04	193	97	6	6223_UP
Drug	Phenazopyridine hydrochloride [136-40-3]; Down 200; 16uM; PC3; HT_HG-U133A	SRCAP BCR PHLDB1 SCN10A CABIN1 CDON	1.79e-04	193	97	6	5758_DN
Drug	Flunisolide [3385-03-3]; Down 200; 9.2uM; MCF7; HT_HG-U133A	PLEKHA6 SRCAP NFATC3 TMEM209 CTNND2 POU2F3	1.84e-04	194	97	6	3828_DN
Drug	ICI 182,780; Down 200; 0.01uM; HL60; HT_HG-U133A	ZSWIM8 ARHGEF12 NFATC3 TMEM209 PLEC CABIN1	1.84e-04	194	97	6	1179_DN
Drug	Kawain [500-64-1]; Down 200; 17.4uM; PC3; HT_HG-U133A	ARHGEF12 WAC MEGF8 YLPM1 CUZD1 CDON	1.89e-04	195	97	6	3670_DN
Drug	Ifenprodil tartrate [23210-58-4]; Down 200; 8.4uM; MCF7; HT_HG-U133A	FXR2 PHLDB1 SIPA1L1 YLPM1 TMEM209 ZBTB3	1.89e-04	195	97	6	7404_DN
Drug	Cimetidine [51481-61-9]; Up 200; 15.8uM; PC3; HG-U133A	MAP1A PHLDB1 SCN5A SCN10A FGFR1 MUC6	1.89e-04	195	97	6	1884_UP
Drug	Pilocarpine nitrate [148-72-1]; Up 200; 14.8uM; MCF7; HT_HG-U133A	ZSWIM8 BAG4 NR1D1 BCR ZCCHC14 EGR1	1.89e-04	195	97	6	3300_UP
Drug	Phentolamine hydrochloride [73-05-2]; Up 200; 12.6uM; MCF7; HT_HG-U133A	SRCAP KLF13 EGR1 PAX8 CUZD1 FGFR1	1.89e-04	195	97	6	3860_UP
Drug	Famprofazone [22881-35-2]; Up 200; 10.6uM; MCF7; HT_HG-U133A	CUX2 SETD1B PLEKHA6 SRCAP MEGF8 EGR1	1.89e-04	195	97	6	3834_UP
Drug	Ramipril [87333-19-5]; Up 200; 9.6uM; PC3; HT_HG-U133A	ACAD10 BCR KLF13 CTNND2 CABIN1 CDON	1.89e-04	195	97	6	7144_UP
Drug	Cephalexin monohydrate [23325-78-2]; Down 200; 11uM; MCF7; HT_HG-U133A	HIVEP2 PLEKHA6 SIK3 SIPA1L1 YLPM1 FGFR1	1.94e-04	196	97	6	5615_DN
Drug	Iodipamide [606-17-7]; Up 200; 3.6uM; MCF7; HT_HG-U133A	SRCAP TRPM3 PAX8 GLI2 FGFR1 CABIN1	1.94e-04	196	97	6	6490_UP
Drug	Tranylcypromine hydrochloride [1986-47-6]; Up 200; 23.6uM; PC3; HT_HG-U133A	WIPI1 MAP1A BCR PHLDB1 EGR1 PAX8	1.94e-04	196	97	6	2101_UP
Drug	Tolbutamide [64-77-7]; Down 200; 14.8uM; PC3; HT_HG-U133A	FXR2 SRCAP WAC PHLDB1 TMEM209 FGFR1	1.94e-04	196	97	6	4540_DN
Drug	Antimycin A [1397-94-0]; Up 200; 7.2uM; HL60; HG-U133A	WIPI1 ARHGEF12 SRCAP TRPM3 EGR1 LPP	1.94e-04	196	97	6	1414_UP
Drug	trichostatin A; Down 200; 0.1uM; HL60; HG-U133A	DDR2 PHLDB1 TRPM3 PRRC2C FGFR1 SRRM2	1.94e-04	196	97	6	364_DN
Drug	Protoveratrine A [143-57-7]; Up 200; 5uM; MCF7; HT_HG-U133A	MAP1A SORBS1 SRCAP ZCCHC14 PHLDB1 MEGF8	1.94e-04	196	97	6	2800_UP
Drug	Scopolamin-N-oxide hydrobromide [6106-81-6]; Down 200; 10uM; PC3; HT_HG-U133A	ACAD10 LPP YLPM1 CABIN1 ZBTB3 SRRM2	1.94e-04	196	97	6	6335_DN
Drug	Chlorpropamide [94-20-2]; Up 200; 14.4uM; MCF7; HT_HG-U133A	SETD1B FXR2 BAG4 PHLDB1 PAX8 SIPA1L1	1.94e-04	196	97	6	3210_UP
Drug	Zaprinast [37762-06-4]; Up 200; 14.8uM; MCF7; HT_HG-U133A	MAP1B ARHGEF12 ZCCHC14 USP2 PHLDB1 SIPA1L1	2.00e-04	197	97	6	5349_UP
Drug	Ethamsylate [2624-44-4]; Down 200; 15.2uM; MCF7; HT_HG-U133A	FXR2 BAG4 SRCAP EGR1 PLEC CABIN1	2.00e-04	197	97	6	7335_DN
Drug	Hecogenin [467-55-0]; Down 200; 9.2uM; HL60; HT_HG-U133A	CASS4 WIPI1 MEGF8 EGR1 YLPM1 SCN10A	2.00e-04	197	97	6	2716_DN
Drug	Tetracaone hydrochloride [136-47-0]; Up 200; 13.2uM; MCF7; HT_HG-U133A	FXR2 SORBS1 SRCAP GLI2 SIPA1L1 CABIN1	2.00e-04	197	97	6	2888_UP
Drug	Serotonin hydrochloride [153-98-0]; Up 200; 18.8uM; MCF7; HT_HG-U133A	ARHGEF12 ZCCHC14 PHLDB1 EGR1 NFATC3 CUZD1	2.00e-04	197	97	6	3311_UP
Drug	Tiratricol, 3,3',5-triiodothyroacetic acid [51-24-1]; Down 200; 6.4uM; MCF7; HT_HG-U133A	MAP1B SORBS1 SRCAP NR1D1 EGR1 TMEM209	2.00e-04	197	97	6	2259_DN
Drug	Carbimazole [22232-54-8]; Up 200; 21.4uM; MCF7; HT_HG-U133A	ARHGEF12 NR1D1 ZCCHC14 KLF13 CUZD1 FGFR1	2.00e-04	197	97	6	3299_UP
Drug	rosiglitazone; Down 200; 10uM; MCF7; HT_HG-U133A	NR1D1 ABLIM1 EGR1 YLPM1 TMEM131L FGFR1	2.00e-04	197	97	6	1658_DN
Drug	PNU-0251126 [267429-19-6]; Down 200; 1uM; PC3; HT_HG-U133A	HIVEP2 MAP1B SORBS1 SRCAP MEGF8 CDON	2.00e-04	197	97	6	3692_DN
Drug	Benzydamine hydrochloride [132-69-4]; Down 200; 11.6uM; PC3; HT_HG-U133A	ARHGEF12 BCR ABLIM1 NFATC3 LPP YLPM1	2.00e-04	197	97	6	5811_DN
Drug	Triamcinolone [124-94-7]; Up 200; 10.2uM; MCF7; HT_HG-U133A	ZCCHC14 MEGF8 TRPM3 TMEM209 FGFR1 POU2F3	2.00e-04	197	97	6	2241_UP
Drug	Sulfathiazole [72-14-0]; Down 200; 15.6uM; MCF7; HT_HG-U133A	WIPI1 HIVEP2 ACAD10 SRCAP NR1D1 CTNND2	2.00e-04	197	97	6	1463_DN
Drug	Delsoline [509-18-2]; Up 200; 8.6uM; MCF7; HT_HG-U133A	MAP1A ARHGEF12 SRCAP PHLDB1 MEGF8 LPP	2.00e-04	197	97	6	7212_UP
Drug	Piromidic acid [19562-30-2]; Down 200; 13.8uM; PC3; HT_HG-U133A	ACAD10 MEGF8 TMEM209 TMEM131L FGFR1 CDON	2.00e-04	197	97	6	4575_DN
Drug	Hesperidin [520-26-3]; Up 200; 6.6uM; PC3; HT_HG-U133A	NR1D1 TRPM3 PAX8 FGFR1 CTNND2 MUC6	2.00e-04	197	97	6	6714_UP
Drug	Trioxsalen [3902-71-4]; Down 200; 17.6uM; MCF7; HT_HG-U133A	MAP1B FXR2 SIK3 TRIM24 EMD CTNND2	2.00e-04	197	97	6	6216_DN
Drug	Sulfamethoxazole [723-46-6]; Up 200; 15.8uM; MCF7; HT_HG-U133A	PHLDB1 MEGF8 NFATC3 CUZD1 SCN10A MUC6	2.00e-04	197	97	6	4690_UP
Drug	Vincamine [1617-90-9]; Down 200; 11.2uM; MCF7; HT_HG-U133A	SRCAP FRMD4B ABLIM1 NFATC3 SIPA1L1 FGFR1	2.00e-04	197	97	6	3865_DN
Drug	AG-013608 [351320-38-2]; Down 200; 10uM; MCF7; HT_HG-U133A	CASS4 ACAD10 USP2 PHLDB1 EGR1 FGFR1	2.05e-04	198	97	6	5904_DN
Drug	Meropenem [96036-03-2]; Down 200; 10.4uM; MCF7; HT_HG-U133A	FXR2 ARHGEF12 GRAMD4 EGR1 YLPM1 PLEC	2.05e-04	198	97	6	7180_DN
Drug	rotenone; Down 200; 1uM; MCF7; HT_HG-U133A	MAP1A NR1D1 PHLDB1 CUZD1 ZBTB3 CDON	2.05e-04	198	97	6	5943_DN
Drug	Tremorine dihydrochloride [300-68-5]; Down 200; 15uM; PC3; HT_HG-U133A	MAP1A FXR2 SRCAP EGR1 SIPA1L1 LPP	2.05e-04	198	97	6	5799_DN
Drug	Mevalonic-D, L acid lactone [674-26-0]; Down 200; 30.8uM; PC3; HT_HG-U133A	HIVEP2 MAP1B NR1D1 SCN10A SRRM2 CDON	2.05e-04	198	97	6	5738_DN
Drug	Cortisone [53-06-5]; Down 200; 11uM; MCF7; HT_HG-U133A	WIPI1 FXR2 LPP TMEM209 FGFR1 PLEC	2.05e-04	198	97	6	7416_DN
Disease	pulse pressure measurement	TET2 SHROOM3 CUX2 MAP1B PODXL COL27A1 ARHGEF12 ACAD10 ZCCHC2 SRCAP FIGN TTC8 MEGF8 TRPM3 ZNF827 LPP SCN10A FGD5 CTNND2	9.81e-08	1392	96	19	EFO_0005763
Disease	cardiovascular age measurement	VGLL2 SIPA1L1 SCN5A SCN10A	2.35e-06	29	96	4	EFO_0803380
Disease	PR interval	FIGN FRMD4B ZNF469 TRPM3 SIPA1L1 SCN5A SCN10A FGFR1 PLEC CTNND2	5.01e-06	495	96	10	EFO_0004462
Disease	QRS complex, QRS duration	DDR2 SIPA1L1 SCN5A SCN10A	1.42e-05	45	96	4	EFO_0005054, EFO_0005055
Disease	Lobar Holoprosencephaly	GLI2 FGFR1 CDON	1.81e-05	16	96	3	C0431362
Disease	Semilobar Holoprosencephaly	GLI2 FGFR1 CDON	1.81e-05	16	96	3	C0751617
Disease	coronary artery disease	TET2 SHROOM3 CUX2 WIPI1 HIVEP2 MAP1B CIART ARHGEF12 ACAD10 FIGN TRPM3 ZNF827 FGD5 CABIN1	3.16e-05	1194	96	14	EFO_0001645
Disease	calcium measurement	TET2 MAP1A CHD8 SIK3 ZCCHC2 ALKBH5 PAX8 FGFR1 PLEC PARP15	3.87e-05	628	96	10	EFO_0004838
Disease	electrocardiography	VGLL2 DDR2 PLEKHA6 TRPM3 SIPA1L1 SCN5A SCN10A FGFR1 PLEC	5.90e-05	530	96	9	EFO_0004327
Disease	Brugada ECG Pattern	SCN5A SCN10A	6.26e-05	4	96	2	C1721096
Disease	obsolete_red blood cell distribution width	WIPI1 SETD1B FXR2 CIART SIK3 ZCCHC2 KLF13 COG1 MUC17 PRRC2C YLPM1 FGFR1 SMCR8 CDCA5	1.15e-04	1347	96	14	EFO_0005192
Disease	coffee consumption	CUX2 ACAD10 YLPM1	1.55e-04	32	96	3	EFO_0004330
Disease	Squamous cell carcinoma of lung	DDR2 TRIM24 FGFR1	1.55e-04	32	96	3	C0149782
Disease	neuroimaging measurement	SHROOM3 MAP1B PODXL ARHGEF12 XPO1 BCR FRMD4B ABLIM1 ZNF469 PRRC2C PLEC AGAP3	1.83e-04	1069	96	12	EFO_0004346
Disease	heart function measurement	SCN5A SCN10A PLEC	1.86e-04	34	96	3	EFO_0004311
Disease	facial emotion recognition measurement	OR7C1 VGLL2 CTNND2	2.03e-04	35	96	3	EFO_0008329
Disease	atrial fibrillation	CUX2 VGLL2 ACAD10 XPO1 FRMD4B SCN5A SCN10A	2.14e-04	371	96	7	EFO_0000275
Disease	electrocardiography, PR interval	SCN5A SCN10A	2.18e-04	7	96	2	EFO_0004327, EFO_0004462
Disease	neutrophil measurement	WAC LPP TMEM131L PLEC NUP153	2.89e-04	177	96	5	EFO_0803548
Disease	Autistic behavior	CUX2 TRPM3	2.90e-04	8	96	2	C0856975
Disease	pancreatic cancer (is_marker_for)	BAG4 MUC16 XPO1 MUC6	3.37e-04	101	96	4	DOID:1793 (is_marker_for)
Disease	interleukin 25 measurement	ARHGEF12 POU2F3	3.72e-04	9	96	2	EFO_0008182
Disease	supraventricular ectopy	SCN5A SCN10A	3.72e-04	9	96	2	EFO_0009277
Disease	very long-chain saturated fatty acid measurement	LCA5 SLC26A9 CTNND2	4.01e-04	44	96	3	EFO_0006796
Disease	cortical surface area measurement	TET2 SHROOM3 PODXL ARHGEF12 XPO1 BCR FRMD4B ZNF469 TJP1 PRRC2C FGFR1 OLIG1 AGAP3	4.14e-04	1345	96	13	EFO_0010736
Disease	fish oil supplement exposure measurement, triglyceride measurement	MAP1A SIK3	4.63e-04	10	96	2	EFO_0004530, EFO_0600007
Disease	generalized epilepsy with febrile seizures plus 2 (implicated_via_orthology)	SCN5A SCN10A	4.63e-04	10	96	2	DOID:0111294 (implicated_via_orthology)
Disease	Dravet syndrome (implicated_via_orthology)	SCN5A SCN10A	4.63e-04	10	96	2	DOID:0080422 (implicated_via_orthology)
Disease	Holoprosencephaly sequence	GLI2 FGFR1	4.63e-04	10	96	2	cv:C0079541
Disease	blood copper measurement	CUX2 OR7C1 ACAD10	5.85e-04	50	96	3	EFO_0007578
Disease	Polydactyly	TTC8 MEGF8 GLI2 FGFR1	5.89e-04	117	96	4	C0152427
Disease	red blood cell density measurement	TET2 SHROOM3 PODXL SORBS1 ACAD10 SIK3 TRPM3 ZNF827 FGD5 PLEC	5.90e-04	880	96	10	EFO_0007978
Disease	urate measurement	CUX2 PODXL DDR2 FRMD4B GRAMD4 USP2 ZNF827 NFATC3 PAX8 FGFR1	6.72e-04	895	96	10	EFO_0004531
Disease	generalized epilepsy with febrile seizures plus (implicated_via_orthology)	SCN5A SCN10A	6.77e-04	12	96	2	DOID:0060170 (implicated_via_orthology)
Disease	Myeloproliferative disease	BCR FGFR1	6.77e-04	12	96	2	C0027022
Disease	corneal resistance factor	TET2 DDR2 ARHGEF12 NR1D1 ZNF469 TRPM3 TJP1	6.89e-04	451	96	7	EFO_0010067
Disease	blood urea nitrogen measurement	SHROOM3 CUX2 ACAD10 PLEKHA6 PHLDB1 NFATC3 PAX8	6.98e-04	452	96	7	EFO_0004741
Disease	serum albumin measurement	SHROOM3 WIPI1 MAP1A SIK3 ZCCHC2 ALKBH5 KLF13 PLEC	7.07e-04	592	96	8	EFO_0004535
Disease	plasminogen activator inhibitor 1 measurement	MUC12 FRMD4B MUC17	7.34e-04	54	96	3	EFO_0004792
Disease	alcohol dependence measurement	PODXL FIGN FGD5	7.74e-04	55	96	3	EFO_0007835
Disease	Brugada Syndrome 1	SCN5A SCN10A	7.98e-04	13	96	2	C4551804
Disease	uric acid measurement	TET2 SHROOM3 CUX2 VGLL2 ACAD10 PLEKHA6 USP2 ZNF827	8.58e-04	610	96	8	EFO_0004761
Disease	T wave morphology measurement	SCN5A SCN10A	9.29e-04	14	96	2	EFO_0008398
Disease	chronic kidney disease	SHROOM3 FIGN MUC17 LPP CDON	1.04e-03	235	96	5	EFO_0003884
Disease	myelodysplastic syndrome (implicated_via_orthology)	TET2 EGR1	1.07e-03	15	96	2	DOID:0050908 (implicated_via_orthology)
Disease	P wave duration	SCN5A SCN10A	1.07e-03	15	96	2	EFO_0005094
Disease	Alobar Holoprosencephaly	GLI2 CDON	1.07e-03	15	96	2	C0431363
Disease	lung non-small cell carcinoma (is_implicated_in)	TET2 XPO1 FGFR1 TNFRSF1A	1.12e-03	139	96	4	DOID:3908 (is_implicated_in)
Disease	monocyte count	TET2 FXR2 DDR2 SH2D3C ARHGEF12 PLEKHA6 XPO1 LPP YLPM1 TMEM131L TNFRSF1A CABIN1	1.19e-03	1320	96	12	EFO_0005091
Disease	cholangiocarcinoma (is_marker_for)	MUC16 MUC3A MUC6	1.20e-03	64	96	3	DOID:4947 (is_marker_for)
Disease	Romano-Ward Syndrome	SCN5A SCN10A	1.22e-03	16	96	2	C0035828
Disease	Holoprosencephaly	GLI2 CDON	1.38e-03	17	96	2	C0079541
Disease	resting heart rate	FRMD4B SCN5A SCN10A PLEC	1.45e-03	149	96	4	EFO_0004351
Disease	asthma, response to diisocyanate	CMYA5 FIGN KLF13 GLI2 TMEM131L	1.66e-03	261	96	5	EFO_0006995, MONDO_0004979
Disease	Paroxysmal atrial fibrillation	XPO1 FRMD4B SCN5A SCN10A	1.71e-03	156	96	4	C0235480
Disease	familial atrial fibrillation	XPO1 FRMD4B SCN5A SCN10A	1.71e-03	156	96	4	C3468561
Disease	Persistent atrial fibrillation	XPO1 FRMD4B SCN5A SCN10A	1.71e-03	156	96	4	C2585653
Disease	Brugada syndrome	SCN5A SCN10A	1.73e-03	19	96	2	MONDO_0015263
Disease	alkaline phosphatase measurement	TET2 CUX2 WIPI1 MAP1A ACAD10 WAC PHLDB1 ZNF827 NFATC3 ALPK2	1.73e-03	1015	96	10	EFO_0004533
Disease	Antihypertensive use measurement	HIVEP2 DDR2 FIGN KLF13 FGD5	1.77e-03	265	96	5	EFO_0009927
Disease	QT interval	FRMD4B SCAP SIPA1L1 SCN5A SCN10A TMEM131L PARP15	1.82e-03	534	96	7	EFO_0004682
Disease	Atrial Fibrillation	XPO1 FRMD4B SCN5A SCN10A	1.88e-03	160	96	4	C0004238
Disease	Infiltrating duct carcinoma of female breast	SMG1 FGFR1	2.11e-03	21	96	2	C3165106
Disease	Cleft palate, cleft lip	SHROOM3 CUX2 MAP1B FIGN FGFR1	2.21e-03	279	96	5	EFO_0003959, HP_0000175
Disease	hypothyroidism (biomarker_via_orthology)	MAP1A MAP1B NR1D1	2.29e-03	80	96	3	DOID:1459 (biomarker_via_orthology)
Disease	neuroticism measurement, cognitive function measurement	TET2 FIGN ZCCHC14 SCAP SIPA1L1 YLPM1 CTNND2	2.52e-03	566	96	7	EFO_0007660, EFO_0008354
Disease	acute myeloid leukemia (is_implicated_in)	TET2 LPP FGFR1	2.63e-03	84	96	3	DOID:9119 (is_implicated_in)
Disease	Brugada Syndrome (disorder)	SCN5A SCN10A	2.76e-03	24	96	2	C1142166
Disease	QRS duration	DDR2 XPO1 SIPA1L1 SCN5A SCN10A	2.94e-03	298	96	5	EFO_0005055
Disease	visual epilepsy (biomarker_via_orthology)	MAP1B EGR1 FGFR1	3.19e-03	90	96	3	DOID:11832 (biomarker_via_orthology)
Disease	eosinophil count	TET2 CUX2 HIVEP2 ACAD10 XPO1 SIK3 WAC LPP PLEC TNFRSF1A OLIG1 ALPK2	3.21e-03	1488	96	12	EFO_0004842

Protein segments in the cluster

Peptide	Gene	Start	Entry
STEVPSTYRSSGNSP	BAG4	166	O95429
STYRSSGNSPTPVSR	BAG4	171	O95429
FSDYSSSVPSTPSIS	AGAP3	296	Q96P47
YSRLETLGSASTSTP	CDCA5	146	Q96FF9
YPSSPVTTASGTTLR	CHD8	2516	Q9HCK8
ESRPHALPSSSSTFY	CASS4	266	Q9NQ75
TSSESIYSRPGSSIP	ABLIM1	351	O14639
PSLTSFVYSPHSTEA	ADGRG4	1831	Q8IZF6
SSGQSSRVSPSPTTY	BCR	346	P11274
PSAADTTATPASYSS	ALPK2	966	Q86TB3
SLSSSVLPPSYASDR	ALKBH5	296	Q6P6C2
TTSSRSYVPSAPAGL	GRAMD4	416	Q6IC98
TGSRSYSSVPEASPA	ACAD10	631	Q6JQN1
LSRPYASVSPSLSSS	CUX2	796	O14529
YSSSRTPSISPVRVS	CTNND2	1051	Q9UQB3
YSPRTSTESFAPRDS	ARHGEF12	1326	Q9NZN5
YSSTSRPSAPPTTAT	PAX8	431	Q06710
PTFSLTPGFRETSTS	MUC16	9871	Q8WXI7
TATSFQTTTTYPTPS	MUC6	1816	Q6W4X9
ATSFQTTTTYPTPSH	MUC6	1986	Q6W4X9
FSPSPSAPSTVSSYV	MUC6	2131	Q6W4X9
SSPTAASTTHRYPKT	PODXL	316	O00592
FSSQSSRALTPPSYS	FIGN	391	Q5HY92
EVFEYSSSTRPITSP	PARP15	226	Q460N3
ATASPPTDGTTRYSA	MAP1A	1261	P78559
ESSPLYSPTFSDSTS	MAP1B	1791	P46821
SYPSSPASAVSLTSS	MAGEB17	66	A8MXT2
PRPTSRYNSSSISSV	FXR2	496	P51116
PPNSSSSDVRTVSYT	DDR2	671	Q16832
VASSATSSLSSYPSP	EGR1	431	P18146
SRSTPTSETTYTTSP	MUC3A	326	Q02505
ITRSTPTSETTYPTS	MUC3A	1076	Q02505
PRSISFPSADTSDYE	FGD5	761	Q6ZNL6
LTFSPDSSTPCTLSY	MEGF8	1326	Q7Z7M0
VPASYTTASTSSRPT	LPP	206	Q93052
SPERSPKTYRFSESS	LCA5	501	Q86VQ0
ISPYFSSRRSSEASP	GLI2	826	P10070
VGYRQPPSSSSSSTS	OLIG1	36	Q8TAK6
STPSSYPSLSEVFGR	POU2F3	266	Q9UKI9
GSSPSRTSPESLYSD	NR1D1	21	P20393
FGVYLSSAATPSSRT	OR7C1	256	O76099
QVPCSPSSRASSYSS	FRMD4B	936	Q9Y2L6
SYTSVATTSFPLHSP	CABIN1	341	Q9Y6J0
SSSSRYSPVLSRFPI	COG1	161	Q8WTW3
YSPSFPDTRSSTCSS	FGFR1	776	P11362
SSSSRSSSPYSKSPV	BCLAF1	141	Q9NYF8
SSTSASEFSVPPYAT	CMYA5	896	Q8N3K9
SSVSSDLAPYFTSEP	CDON	21	Q4KMG0
QFLSSSPRPTSSGYS	COL27A1	596	Q8IZC6
DYSRSDASSPTISPA	KLF13	271	Q9Y2Y9
RRLSPPSSSAASSYS	EMD	46	P50402
TCRASPTSDFASPTY	CUZD1	441	Q86UP6
CYLSTTPSTNTTRTP	C4orf54	431	D6RIA3
RGSSPASPVYSSSDT	SCAP	1051	Q12770
PADTSTPVTTYSQAS	MUC17	1066	Q685J3
YSLVRESSSSRSPTP	SRRM2	171	Q9UQ35
HASFISSPPYLTSTR	TMEM131L	1511	A2VDJ0
SVSYITFSPDSSSPA	SLC26A9	621	Q7LBE3
SSPTSSATYQPSFAA	SMG1	3526	Q96Q15
SVTDYTTPSSSLPNT	PRRC2C	2186	Q9Y520
SSISSTSFPPSYDSV	SCN5A	1966	Q14524
TSFPPSYDSVTRATS	SCN5A	1971	Q14524
SSSSSSSSGPRSFYP	SIPA1L1	1461	O43166
SDQSRGSPSSYSPST	SIK3	896	Q9Y2K2
SSFSTSSSILEYPHP	SHROOM3	261	Q8TF72
TPFSQDSSYSSRQPT	SETD1B	281	Q9UPS6
YVSSFPRAPSTSDSV	TCEA1	126	P23193
TSDASSPRSYVSPRI	WAC	441	Q9BTA9
GYTFPPAAATTTSTT	SRCAP	1136	Q6ZRS2
VASTSSDRIPSAYPA	SMCR8	681	Q8TEV9
SSYSLSSSFPTSPVN	CIART	11	Q8N365
TSYSPRPTDSCFSSS	C12orf40	481	Q86WS4
TSSESYSSPSSPRHD	ZCCHC2	631	Q9C0B9
PLSSESPRGADSSYT	PLEKHA6	1031	Q9Y2H5
STPSSPTITSAAGYD	TRIM24	586	O15164
YRESPFSTSASPLLS	XPO1	381	O14980
TPRTAYTARPITSSS	TTC8	141	Q8TAM2
SSYSPSCTSSKAPRS	VGLL2	111	Q8N8G2
TASATSFPPSYESVT	SCN10A	1911	Q9Y5Y9
FSTPVPSTAPSSSAY	TRPM3	1456	Q9HCF6
SSSYRETPSSSPASP	SORBS1	76	Q9BX66
DEVYSRPSSLVSSSP	TBC1D9	421	Q6ZT07
TYEPSSATPVTRSSQ	TTC3	1911	P53804
SYRESSLSPSPASSI	NFATC3	156	Q12968
VYTRPAISSFSSSGI	NUP153	636	P49790
SVGSSSSYPISPAVS	PLEC	4386	Q15149
SSYENTSPAFSPLSS	PHLDB1	246	Q86UU1
YSSSTTPAAPSSSGF	YLPM1	36	P49750
SYSPSRSPSTSPKFT	TMEM209	141	Q96SK2
EPPSSFTSTNYTSPS	ZNF469	186	Q96JG9
PRSSYVFSPESEVSA	ZNF827	611	Q17R98
SYSPQADSLRTPSTE	TJP1	966	Q07157
SSPALSSVPESSFYS	ZCCHC14	731	Q8WYQ9
PQTLSSFYSSSRPTT	ZSWIM8	1021	A7E2V4
SESPSSPAYSTVTRV	SH2D3C	411	Q8N5H7
ARPSASSASTVPGYS	WIPI1	386	Q5MNZ9
PATYTSFSPGLSTCS	nan	11	Q5VSD8
TSSFLTRPRTYGPSS	USP2	56	O75604
SSSQDYPSVSPSSRE	HIVEP2	1521	P31629
DSTVTTSPYAFTRVT	TET2	1981	Q6N021
STFTSSSTYTPGDCP	TNFRSF1A	291	P19438
QSPSSSNYFSPREST	ZBTB22	201	O15209
SPSSSTETIPTNYFS	ZBTB3	271	Q9H5J0
STPSSSDPFTTFSDY	MUC12	181	Q9UKN1
TTFYSSPRSPDRTLS	MUC12	281	Q9UKN1
STTFYSSPRSPDTTH	MUC12	636	Q9UKN1
SEASTTFYSSPRSPT	MUC12	1241	Q9UKN1
TFYSSPRSPTTTLSP	MUC12	1246	Q9UKN1
TTFYTSPRSPDATLS	MUC12	1441	Q9UKN1
STTFYSSPRSPDTTL	MUC12	1691	Q9UKN1
PGLSEASTTFYSSPR	MUC12	2321	Q9UKN1
ASTTFYSSPRSPTTT	MUC12	2326	Q9UKN1
EKSTTFYTSPRSPDA	MUC12	2521	Q9UKN1
GLSEASTTFYSSPRS	MUC12	2796	Q9UKN1
STTFYSSPRSPTTTL	MUC12	2801	Q9UKN1
YSSSPGSTETTVFPR	MUC12	2861	Q9UKN1
KSTTFYTSPRSPDAT	MUC12	2996	Q9UKN1
EKSTTFYSSPRSPDT	MUC12	3246	Q9UKN1
SEASTTFYSSPRSPT	MUC12	3881	Q9UKN1
TFYSSPRSPTTTLSP	MUC12	3886	Q9UKN1
TTFYTSPRSPDATLS	MUC12	4081	Q9UKN1
STTFYSSPRSPDTTL	MUC12	4331	Q9UKN1
PSTSERTSPGTSSAY	NACC1	256	Q96RE7
RTSPGTSSAYTSDSP	NACC1	261	Q96RE7